Category,FY,Funding IC,Project Number,Sub Project #,Project Title,PI Name,Org Name,State / Country,Amount
Lung Cancer,2009,NCI,4R37CA081301-11,,Metabolism of Carcinogenic Tobacco-Specific Nitrosamines,"HECHT, STEPHEN",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$510,309"
Lung Cancer,2009,NCI,5R01CA115707-03,,Targeting Notch3 in Lung Cancer,"DANG, THAO",VANDERBILT UNIVERSITY,TN,"$262,485"
Lung Cancer,2009,NCI,5R01CA122474-02,,Mechanistic Studies on Lung Cancer Prevention by Tea Polyphenols,"YANG, CHUNG",RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK,NJ,"$319,457"
Lung Cancer,2009,NCI,5R01CA127105-02,,FGF-2 Autocrine Signaling in Lung Cancer,"HEASLEY, LYNN",UNIVERSITY OF COLORADO DENVER,CO,"$314,653"
Lung Cancer,2009,NCI,5R01CA125541-03,,Studies of a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC),"SALGIA, RAVI",UNIVERSITY OF CHICAGO,IL,"$262,485"
Lung Cancer,2009,NCI,5R01CA127219-02,,Inflammation Genes and Lung Cancer Risk,"SPITZ, MARGARET",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$602,949"
Lung Cancer,2009,NCI,5R01CA116527-03,,Role of JNK Pathway in Lung Tumorigenesis,"HEASLEY, LYNN",UNIVERSITY OF COLORADO DENVER,CO,"$255,132"
Lung Cancer,2009,NCI,5R01CA120174-03,,Lung Epithelial-Mesenchymal Interactions in Adenocarcinoma Invasion,"POWELL, CHARLES",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$401,140"
Lung Cancer,2009,NCI,5R01CA113793-04,,Chemoprevention with mTOR & Farnesyltransferase Inhibitors,"YOU, MING",WASHINGTON UNIVERSITY,MO,"$261,975"
Lung Cancer,2009,NCI,5R01CA127580-02,,Molecular Mechanisms of EGF Signaling & Iressa/Tarceva Inhibition in NSCLC,"ANDERSON, KAREN",YALE UNIVERSITY,CT,"$323,966"
Lung Cancer,2009,NIAID,5R01AI073558-02,,Brucella epitope recognition by CD8+ T cells,"SPLITTER, GARY",UNIVERSITY OF WISCONSIN MADISON,WI,"$367,500"
Lung Cancer,2009,NCI,5R01CA112405-05,,A Molecular Basis for Neuroendocrine Carcinogenesis,"GRIMES, H",CHILDREN'S HOSPITAL MED CTR (CINCINNATI),OH,"$233,253"
Lung Cancer,2009,NCI,5R01CA118015-02,,Role of PP2A in Lung Cancer,"WALTER, GERNOT",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$320,588"
Lung Cancer,2009,NIGMS,5R01GM076343-04,,Structural Basis of Cytochrome P450 2A13 Activity,"SCOTT, EMILY",UNIVERSITY OF KANSAS LAWRENCE,KS,"$270,669"
Lung Cancer,2009,NCI,5R01CA107972-05,,Survival Signaling After Genotoxic Insult,"CERYAK, SUSAN",GEORGE WASHINGTON UNIVERSITY,DC,"$237,918"
Lung Cancer,2009,NCI,5R01CA116020-04,,Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma,"MEYERSON, MATTHEW",DANA-FARBER CANCER INSTITUTE,MA,"$333,806"
Lung Cancer,2009,NCI,5R01CA132012-02,,Nanoimmunoliposome-Complexed SPIO: Tumor-Specific Detection of Early Lung Cancer,"CHANG, ESTHER",GEORGETOWN UNIVERSITY,DC,"$633,229"
Lung Cancer,2009,NCI,5R21CA127787-02,,Parents Awareness Reducing Exposure to Nicotine and Tobacco (PARENT),"MURAMOTO, MYRA",UNIVERSITY OF ARIZONA,AZ,"$169,875"
Lung Cancer,2009,NCI,5R01CA127532-02,,Molecular Epidemiology and Lung Cancer: A Nested Case-Control Study,"PERERA, FREDERICA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$404,835"
Lung Cancer,2009,NCI,5R21CA128193-03,,A Phase I/II Clinical Trial of Intravenous (I.V.) Calcitriol with Fixed Doses of,"RAMNATH, NITHYA",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$378,381"
Lung Cancer,2009,NCI,5R21CA127057-02,,FDG-PET and V/Q SPECT Acquired During Radiation to Predict Outcomes in Lung Cance,"KONG, FENG-MING",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$171,000"
Lung Cancer,2009,NCI,5R01CA126969-03,,Assessment of a Teachable Moment for Smoking Cessation,"SCHNOLL, ROBERT",UNIVERSITY OF PENNSYLVANIA,PA,"$306,648"
Lung Cancer,2009,NCI,5R01CA119028-05,,Mechanisms of As-Induced Carcinogenesis,"SHI, XIANGLIN",UNIVERSITY OF KENTUCKY,KY,"$227,247"
Lung Cancer,2009,NCI,5R01CA116697-03,,Oxidative Stress in Cr(VI)-induced Carcinogenesis,"SHI, XIANGLIN",UNIVERSITY OF KENTUCKY,KY,"$278,350"
Lung Cancer,2009,NCI,5R01CA077262-12,,Nucleoporins in Chromosomal Instability and Cancer,"VAN DEURSEN, JAN","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$312,108"
Lung Cancer,2009,NCI,5R01CA106567-06,,Role of Cell Mediators in Asbestos-SV40 Carcinogenesis,"CARBONE, MICHELE",UNIVERSITY OF HAWAII AT MANOA,HI,"$262,839"
Lung Cancer,2009,NCI,5R01CA111851-04,,Novel COX-2 and PGE2-dependent pathways in lung cancer,"DUBINETT, STEVEN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$239,656"
Lung Cancer,2009,NCI,5R01CA112385-05,,Pharmacodynamic Assessment of RTK Inhibitors in Cancer,"HALLAHAN, DENNIS",VANDERBILT UNIVERSITY,TN,"$68,140"
Lung Cancer,2009,NIDCR,5R01DE013123-08,,Genomic Scanning for Genetic and Epigenetic Alterations in head and neck cancer,"PLASS, CHRISTOPH",GERMAN CANCER RESEARCH CENTER,GERM,"$261,900"
Lung Cancer,2009,NIEHS,5R01ES006717-13,,Biomarkers of Lung Cancer Susceptibility in Minorities,"WIENCKE, JOHN",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$793,154"
Lung Cancer,2009,NCI,5R01CA122994-03,,Micellar Nanotherapeutics for Targeted Lung Cancer Therapy,"GAO, JINMING",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$268,470"
Lung Cancer,2009,NIEHS,5R01ES008801-09,,Tumor Suppressor Gene Methylation in Lung Adenocarcinoma,"BELINSKY, STEVEN",LOVELACE BIOMEDICAL & ENVIRONMENTAL RES,NM,"$621,892"
Lung Cancer,2009,NCI,1R01CA137008-01,,The Activation of ERBB3 Signaling as a Resistance Mechanism to Targeted Therapies,"ENGELMAN, JEFFREY",MASSACHUSETTS GENERAL HOSPITAL,MA,"$369,945"
Lung Cancer,2009,NCI,7R01CA121210-03,,Overcoming acquired resistance to EGFR inhibitors in lung cancer,"PAO, WILLIAM",VANDERBILT UNIVERSITY,TN,"$264,195"
Lung Cancer,2009,NCI,2P50CA058184-14A1,8042,P1:  Epigenetic Staging and Therapy for Lung Cancers,"HERMAN, JAMES",JOHNS HOPKINS UNIVERSITY,MD,"$426,539"
Lung Cancer,2009,NCI,2P50CA058184-14A1,8044,P2:  Gene Promoter Hypermethylation as a Biomarker for Lung Cancer Detection,"BELINSKY, STEVEN",LOVELACE BIOMEDICAL & ENVIRONMENTAL RES,NM,"$793,806"
Lung Cancer,2009,NCI,2P50CA058184-14A1,8045,P3:  Deregulated NRF2-KEAP1 Pathway as a Critical Regulator of Chemoresistance,"BISWAL, SHYAM",JOHNS HOPKINS UNIVERSITY,MD,"$368,654"
Lung Cancer,2009,NCI,2P50CA058184-14A1,8046,P4:  Inhibition of Fatty Acid Synthase for Lung Cancer Treatment,"GABRIELSON, EDWARD",JOHNS HOPKINS UNIVERSITY,MD,"$225,731"
Lung Cancer,2009,NCI,2P50CA058184-14A1,8049,CA:  Administrative Core,"BAYLIN, STEPHEN",JOHNS HOPKINS UNIVERSITY,MD,"$152,155"
Lung Cancer,2009,NCI,2P50CA058184-14A1,8050,CB:  Human Tissue and Pathology,"GABRIELSON, EDWARD",JOHNS HOPKINS UNIVERSITY,MD,"$374,801"
Lung Cancer,2009,NCI,2P50CA058184-14A1,8052,CC:  Statistical Core,"GOODMAN, STEVEN",JOHNS HOPKINS UNIVERSITY,MD,"$155,958"
Lung Cancer,2009,NCI,2P50CA058184-14A1,8054,Development Research Program,"BAYLIN, STEPHEN",JOHNS HOPKINS UNIVERSITY,MD,"$380,387"
Lung Cancer,2009,NCI,2P50CA058184-14A1,8058,Career Development Program,"BAYLIN, STEPHEN",JOHNS HOPKINS UNIVERSITY,MD,"$131,234"
Lung Cancer,2009,NIDCR,5R01DE014173-08,,EPITHELIAL ACETYLCHOLINE IN ORAL BIOLOGY AND PATHOLOGY,"GRANDO, SERGEI",UNIVERSITY OF CALIFORNIA IRVINE,CA,"$370,722"
Lung Cancer,2009,NCI,5R01CA084354-08,,Genetic Determinants of Lung Cancer Survival,"YANG, PING","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$366,188"
Lung Cancer,2009,NIBIB,1R03EB009182-01,,Preclinical Development and Testing of Multifunctional Tumor-Targeted Hybrid Nano,"RAMESH, RAJAGOPAL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$77,000"
Lung Cancer,2009,NCI,5R01CA120528-04,,Validation of Prognostic and Diagnostic molecular tests in Mesothelioma,"BUENO, RAPHAEL",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$301,617"
Lung Cancer,2009,NCI,5R01CA113892-04,,Pathways of Therapy-induced Senescence in Cancer,"WU, DANIEL",SEATTLE INST FOR BIOMEDICAL/CLINICAL RES,WA,"$235,952"
Lung Cancer,2009,NCI,5R01CA113519-04,,Targeting TGF-beta Signaling in Lung Cancer,"DATTA, PRAN",VANDERBILT UNIVERSITY,TN,"$238,105"
Lung Cancer,2009,NCI,5R21CA127064-02,,Discovery of Cancer Imaging Probes using SUPREX,"FITZGERALD, MICHAEL",DUKE UNIVERSITY,NC,"$175,500"
Lung Cancer,2009,NCI,5R01CA120409-04,,Immunotherapy of mesothelin expressing tumors with lentiviral engineered T cells,"JUNE, CARL",UNIVERSITY OF PENNSYLVANIA,PA,"$266,186"
Lung Cancer,2009,NCI,5R01CA113559-04,,The function of RhoBTB proteins,"SOLTOFF, STEPHEN",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$293,000"
Lung Cancer,2009,NCI,5R01CA095568-07,,Biomarkers to Assess Selenium Chemoprevention for NSCLC,"BELINSKY, STEVEN",LOVELACE BIOMEDICAL & ENVIRONMENTAL RES,NM,"$751,952"
Lung Cancer,2009,NINR,1R15NR010801-01A1,,Development of a Biologically-based Nursing Intervention for Cancer Cachexia,"MCCARTHY-BECKETT, DONNA",OHIO STATE UNIVERSITY,OH,"$225,000"
Lung Cancer,2009,NCI,5R01CA111766-04,,Molecular Targeting of Drug Delivery System to Cancer,"MINKO, TAMARA",RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK,NJ,"$266,286"
Lung Cancer,2009,NIAID,1R15AI078373-01A1,,Can Chlamydial Infection Increase Host Mutation Frequency?,"SCHOBORG, ROBERT",EAST TENNESSEE STATE UNIVERSITY,TN,"$210,947"
Lung Cancer,2009,NCI,5R01CA113876-05,,Angioprevention of Lung Tumorigenesis by Silibinin,"AGARWAL, RAJESH",UNIVERSITY OF COLORADO DENVER,CO,"$288,389"
Lung Cancer,2009,NCI,5R21CA133281-02,,Potential Role of Fetal Stem Cells in Lung Tumor Development,"SAWICKI, JANET",LANKENAU INSTITUTE FOR MEDICAL RESEARCH,PA,"$185,625"
Lung Cancer,2009,NCI,5R01CA058554-15,,Molecular genetics of Mouse Lung Tumors,"YOU, MING",WASHINGTON UNIVERSITY,MO,"$248,200"
Lung Cancer,2009,NIEHS,1R01ES017217-01A2,,Mdig gene and histone demethylation in lung cancer,"CHEN, FEI",UNIVERSITY OF KENTUCKY,KY,"$296,663"
Lung Cancer,2009,NCI,5R01CA126944-02,,Novel Immune Pathways for Lung Cancer Therapy,"SHARMA, SHERVEN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$287,595"
Lung Cancer,2009,NCI,5R01CA111834-04,,The role of Kras2 in lung tumor susceptibility,"BALMAIN, ALLAN",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$266,285"
Lung Cancer,2009,NHLBI,5R01HL013645-36,,3-Methylindole-Induced Lung Injury,"YOST, GAROLD",UNIVERSITY OF UTAH,UT,"$464,670"
Lung Cancer,2009,NCI,2R01CA079882-10A1,,Targeting the HGF/c-Met Pathway in Lung Cancer,"SIEGFRIED, JILL",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$299,617"
Lung Cancer,2009,NCI,5R01CA100323-06,,Autoantibodies in NSCLC as Markers for Disease,"HIRSCHOWITZ, EDWARD",UNIVERSITY OF KENTUCKY,KY,"$256,375"
Lung Cancer,2009,NCI,5R01CA124640-03,,Airway gene expression in smokers: an early diagnostic biomarker for lung cancer,"SPIRA, AVRUM",BOSTON UNIVERSITY MEDICAL CAMPUS,MA,"$308,750"
Lung Cancer,2009,NCI,5R21CA122546-02,,NMDA receptors in the diagnosis and treatment of small cell lung cancer.,"NORTH, WILLIAM",DARTMOUTH COLLEGE,NH,"$179,888"
Lung Cancer,2009,NHLBI,5R01HL086598-03,,Epidermal Growth Factor Receptor Activation in Pulmonary Fibrosis,"HARDIE, WILLIAM",CHILDREN'S HOSPITAL MED CTR (CINCINNATI),OH,"$375,000"
Lung Cancer,2009,FIC,5D43TW000653-13,,International Training and Research in Environmental and Occupational Health,"HRYHORCZUK, DANIEL",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$113,730"
Lung Cancer,2009,NIEHS,5D43TW000653-13,,International Training and Research in Environmental and Occupational Health,"HRYHORCZUK, DANIEL",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$30,770"
Lung Cancer,2009,NCI,1R01CA131049-01A1,,Prospective Validation of Genomic Signatures of Chemosensitivity in NSCLC,"POTTI, ANIL",DUKE UNIVERSITY,NC,"$340,464"
Lung Cancer,2009,NCI,5R01CA115309-05,,Role of O6-alkylguanine in nitrosamine-induced cancers,"PETERSON, LISA",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$246,368"
Lung Cancer,2009,NCI,5K08CA120060-04,,Molecular mechanisms of PI3K activation in non-small cell lung cancer,"ENGELMAN, JEFFREY",MASSACHUSETTS GENERAL HOSPITAL,MA,"$142,965"
Lung Cancer,2009,NCI,2R01CA078814-11A1,,New Triterpenoids for Chemoprevention and Therapy of Cancer,"SPORN, MICHAEL",DARTMOUTH COLLEGE,NH,"$351,366"
Lung Cancer,2009,NCI,1R01CA131301-01A1,,Let-7 microRNAs in Lung Cancer: Altering Growth and Radioresistance,"WEIDHAAS, JOANNE",YALE UNIVERSITY,CT,"$339,065"
Lung Cancer,2009,NCI,5R01CA129933-02,,Circumventing Acquired Resistance to Growth Factor Receptor Kinase Inhibitors,"HABER, DANIEL",MASSACHUSETTS GENERAL HOSPITAL,MA,"$366,238"
Lung Cancer,2009,NCI,1R01CA125030-01A2,,Small molecule inhibitors of Wnt-2 transcription in NSCLC,"HE, BIAO",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$320,588"
Lung Cancer,2009,NCI,2R01CA093626-06A2,,4D IMRT: Stereotactic body radiotherapy for lung cancer,"KEALL, PAUL",STANFORD UNIVERSITY,CA,"$318,449"
Lung Cancer,2009,NCI,1R01CA128801-01A1,,Lung carcinogenesis: Chemoprevention by Indole-3-carbinol,"KASSIE, FEKADU",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$250,660"
Lung Cancer,2009,NCI,5R03CA133939-02,,International Lung Cancer Consortium: Pooled Analysis of Genetic Determinants of,"BRENNAN, PAUL",INTERNATIONAL AGENCY FOR RES ON CANCER,FR,"$56,950"
Lung Cancer,2009,NCI,5R01CA129835-02,,LPD Nanoparticles in Anti-Cancer Therapy,"HUANG, LEAF",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$301,708"
Lung Cancer,2009,NCI,2R01CA117840-03A2,,Evaluation of Computerized Decision Support for Managing Lung Nodules,"GOULD, MICHAEL","PALO ALTO INSTITUTE FOR RES & EDU, INC.",CA,"$281,023"
Lung Cancer,2009,NCI,5R01CA118130-02,,PET Proliferation Tracers,"SCHWARTZ, JEFFREY",UNIVERSITY OF WASHINGTON,WA,"$366,878"
Lung Cancer,2009,NCI,1R21CA129260-01A2,,K-ras Mutations in Mouse Bronchiolar Stem Cells as Biomarkers for Lung Cancer,"KEOHAVONG, PHOUTHONE",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$199,980"
Lung Cancer,2009,NCI,5R01CA122244-02,,Randomized trial of PEITC as a modifier of NNK metabolism in smokers,"YUAN, JIAN-MIN",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$605,436"
Lung Cancer,2009,NCI,5R01CA113630-04,,Determinants of Resistance to Erlotinib in NSCLC,"PEREZ-SOLER, ROMAN",ALBERT EINSTEIN COL OF MED YESHIVA UNIV,NY,"$286,106"
Lung Cancer,2009,NCI,5R01CA116158-03,,Relationship of Colon & Lung Cancer Susceptibility Genes,"DEMANT, PETER",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$316,276"
Lung Cancer,2009,NCI,5R01CA133021-02,,Inhibition of Lung Carcinogenesis by Tea Polyphenols and Atorvastatin,"YANG, CHUNG",RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK,NJ,"$319,457"
Lung Cancer,2009,NCI,1K23CA131577-01A1,,Gene Modified Dendritic Cell Therapy in Lung Cancer,"LEE, JAY",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$132,031"
Lung Cancer,2009,NIEHS,1R03ES016605-01A1,,Effects of Lactational Exposure to Chromium (VI) on Ovarian Development,"BANU, SAKHILA",TEXAS A&M UNIVERSITY SYSTEM,TX,"$73,250"
Lung Cancer,2009,NCI,5R01CA121182-03,,Stat3 in EGFR Driven Non-Small Cell Lung Cancer,"HAURA, ERIC",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$316,667"
Lung Cancer,2009,NCRR,1S10RR025419-01,,Purchase of a Triple Quadrupole Mass Spectrometer for Multiple Reaction Monitorin,"COTTER, ROBERT",JOHNS HOPKINS UNIVERSITY,MD,"$413,070"
Lung Cancer,2009,NCI,2R01CA100603-07A1,,Regulation and Role of Ornithine Decarboxylase in Cell Proliferation and Cancer,"CLEVELAND, JOHN",SCRIPPS RESEARCH INSTITUTE,CA,"$422,647"
Lung Cancer,2009,NCI,5R01CA114465-05,,EGFR Mutations in non-Small Cell Lung Cancer,"JOHNSON, BRUCE",DANA-FARBER CANCER INSTITUTE,MA,"$278,041"
Lung Cancer,2009,NCI,5R01CA114541-05,,DNA Damage and Tobacco-Induced Lung Cancer,"TANG, ERIC MOON-SHONG",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$331,480"
Lung Cancer,2009,NCI,2R01CA080065-09A2,,Signaling by Neuregulins and ErbB4 in Breast Cancer,"STERN, DAVID",YALE UNIVERSITY,CT,"$391,179"
Lung Cancer,2009,NCI,1R01CA139959-01A1,,CHEMOPREVENTION OF LUNG SQUAMOUS CELL CARCINOMA WITH POLYPHENON E,"YOU, MING",WASHINGTON UNIVERSITY,MO,"$239,400"
Lung Cancer,2009,OD,1R01CA139959-01A1,,CHEMOPREVENTION OF LUNG SQUAMOUS CELL CARCINOMA WITH POLYPHENON E,"YOU, MING",WASHINGTON UNIVERSITY,MO,"$76,000"
Lung Cancer,2009,NCI,1R01CA134796-01A1,,Investigating the role of p73 and its isoforms in tumorigenesis and metastasis,"FLORES, ELSA",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$319,550"
Lung Cancer,2009,NCI,5R01CA104932-04,,Lycopene Chemoprevention of Lung Cancer in Ferret,"WANG, XIANG-DONG",TUFTS UNIVERSITY BOSTON,MA,"$272,318"
Lung Cancer,2009,NCI,5R21CA123864-02,,Clinical Trial of DRibble Vaccine in NSCLC,"URBA, WALTER",PROVIDENCE PORTLAND MEDICAL CENTER,OR,"$326,925"
Lung Cancer,2009,NCI,5R01CA060691-15,,Genetic Epidemiology of Lung Cancer,"SCHWARTZ, ANN",WAYNE STATE UNIVERSITY,MI,"$584,279"
Lung Cancer,2009,NCI,5R01CA087546-09,,Retinoid Cancer Prevention Mechanisms,"DMITROVSKY, ETHAN",DARTMOUTH COLLEGE,NH,"$273,883"
Lung Cancer,2009,NCI,5R03CA133907-02,,DNA Repair Capacity and Risk of Pre-malignant Lesion in Lung Epithelium,"ZHAO, HUA",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$69,653"
Lung Cancer,2009,NCI,5R03CA133956-02,,A Genetic Test for Lung Cancer Early Detection,"JIANG, FENG",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$75,000"
Lung Cancer,2009,NCI,5R21CA132806-02,,Standardized NanoArray PCR for Gene Expression Profiling of Lung Cancer,"MORRISON, TOM","BIOTROVE, INC.",MA,"$173,300"
Lung Cancer,2009,NIEHS,5R01ES015662-02,,Mutagenesis of p53 by reactive PAH and ROS,"FIELD, JEFFREY",UNIVERSITY OF PENNSYLVANIA,PA,"$313,516"
Lung Cancer,2009,NCI,5U01CA086137-10,,NYU Lung Cancer Biomarker Center,"ROM, WILLIAM",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$1,082,162"
Lung Cancer,2009,NCI,5R01CA129343-02,,RRM1 in the Management of Lung Cancer,"BEPLER, GEROLD",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$571,979"
Lung Cancer,2009,NCI,5R01CA077495-11,,Mechanism of Drug Transport in Lung Cancer Cells,"AWASTHI, SANJAY",UNIVERSITY OF NORTH TEXAS HLTH SCI CTR,TX,"$243,821"
Lung Cancer,2009,NIDCR,5R01DE013158-09,,UDP-GLUCURONOSYLTRANSFERASE GENOTYPE AND CANCER RISK,"LAZARUS, PHILIP",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$497,789"
Lung Cancer,2009,NCI,5R01CA080180-06,,Cancer Risks among Textile Workers in China,"CHECKOWAY, HARVEY",UNIVERSITY OF WASHINGTON,WA,"$505,085"
Lung Cancer,2009,NCI,5R01CA089352-08,,Mechanisms of thymide phosphorylase angiogenesis,"SCHWARTZ, EDWARD","MONTEFIORE MEDICAL CENTER (BRONX, NY)",NY,"$229,616"
Lung Cancer,2009,NCI,5U01CA069856-15,,Early Clinical Trials of New Anti-Cancer Agents with Phase 1 Emphasis,"SPRIGGS, DAVID",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$256,656"
Lung Cancer,2009,NCI,5R01CA111646-05,,Lung Cancer Chemoradiation: Predictors of Survival,"WU, XIFENG",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$538,470"
Lung Cancer,2009,NCCAM,5R21AT003893-02,,Inhibiting Notch activity and brain tumor progression using Zen Sheng Ping (ZSP),"EBERHART, CHARLES",JOHNS HOPKINS UNIVERSITY,MD,"$205,000"
Lung Cancer,2009,NCI,5R01CA127725-02,,Role of Beta-arrestin-1 and Src in nAChR Signaling and Lung Caancer,"CHELLAPPAN, SRIKUMAR",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$346,007"
Lung Cancer,2009,NHLBI,1F30HL093991-01A1,,The Role of Sphingosine Kinase 1 in Ras-initiated Lung Carcinogenesis,"GAULT, CHRISTOPHER",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$36,091"
Lung Cancer,2009,NCI,5R01CA115830-05,,Gefitinib-sensitive EGF receptor mutants in lung cancer,"SETTLEMAN, JEFFREY",MASSACHUSETTS GENERAL HOSPITAL,MA,"$643,108"
Lung Cancer,2009,NCI,5R01CA132608-02,,Inflammation in Oncogenic K-ras-induced Lung Tumorigenesis,"KURIE, JONATHAN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$265,753"
Lung Cancer,2009,NCI,5R01CA132580-02,,Inflammatory Cytokines Link NF-kappaB with Bim Degradation and Metastasis,"MAYO, MARTY",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$284,922"
Lung Cancer,2009,NCI,5R01CA132603-02,,Mechansims of Lung Carcinogenesis Induced by Asbestos and Cigarette Smoke,"SULLIVAN, DEBORAH",TULANE UNIVERSITY OF LOUISIANA,LA,"$285,824"
Lung Cancer,2009,NCI,5R01CA132566-02,,Inflammation and Lung Carcinogenesis,"JABLONS, DAVID",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$293,550"
Lung Cancer,2009,NCI,5R01CA132591-02,,Role of DOK Proteins in Lung Cancer,"ROTHMAN, PAUL",UNIVERSITY OF IOWA,IA,"$285,000"
Lung Cancer,2009,NCI,5R01CA132624-02,,Macrophages and Inflammatory Mediators in Silica-Induced Carcinogenesis,"LASKIN, DEBRA",RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK,NJ,"$297,882"
Lung Cancer,2009,NCI,5R01CA132586-02,,Pulmonary inflammation and lung cancer development and progression,"KARIN, MICHAEL",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$332,354"
Lung Cancer,2009,NCI,5R01CA132571-02,,Regulation of Tumor Associated Macrophages by TGF-beta,"KESHAMOUNI, VENKATESHWAR",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$287,326"
Lung Cancer,2009,NCI,5R01CA068682-19,,Biomedical Applications of Expanded Porphyrins,"SESSLER, JONATHAN",UNIVERSITY OF TEXAS AUSTIN,TX,"$305,354"
Lung Cancer,2009,NIEHS,5F31ES016719-02,,Curcumin inhbits BPDE-induced damage by lowering the threshold of p53 activation,"ROGERS, ERICA",UNIVERSITY OF LOUISVILLE,KY,"$26,684"
Lung Cancer,2009,NCI,5R01CA112231-05,,Relating DNA Adducts and Toxicogenomics,"VOUROS, PAUL",NORTHEASTERN UNIVERSITY,MA,"$435,701"
Lung Cancer,2009,NCI,5R01CA102085-04,,Computerized Analysis of Mesothelioma on CT Scans,"ARMATO, SAMUEL",UNIVERSITY OF CHICAGO,IL,"$261,020"
Lung Cancer,2009,NCI,5R01CA122794-04,,EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors,"WONG, KWOK KIN",DANA-FARBER CANCER INSTITUTE,MA,"$277,591"
Lung Cancer,2009,NHLBI,5R44HL070411-06,,A BREATH TEST FOR LUNG CANCER,"PHILLIPS, MICHAEL","MENSSANA RESEARCH, INC.",NJ,"$982,644"
Lung Cancer,2009,NIEHS,2P42ES013660-05,6031,Project 4: Biological Dosimetry of Hexavalent Chromium,"ZHITKOVICH, ANATOLY",BROWN UNIVERSITY,RI,"$267,378"
Lung Cancer,2009,NCI,5R01CA125564-03,,Urokinase Receptor Integrin Interactions in Lung Cancer,"CHAPMAN, HAROLD",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$293,550"
Lung Cancer,2009,NCI,5R01CA117965-04,,Mediators of Oncogenic KRAS in Lung Adenocarcinoma,"KURIE, JONATHAN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$258,530"
Lung Cancer,2009,NCI,5R01CA116322-03,,Tumor and PTK-Targeted Therapy by FUS1 and PTK inhibitor,"JI, LIN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$292,600"
Lung Cancer,2009,NCI,5R01CA113448-04,,EGFR/Radiation Responses and Resistance Interactions,"HARARI, PAUL",UNIVERSITY OF WISCONSIN MADISON,WI,"$253,359"
Lung Cancer,2009,NCI,5R01CA126939-02,,The Epidemiology of Molecular Alterations in Mesothelioma,"KELSEY, KARL",BROWN UNIVERSITY,RI,"$494,897"
Lung Cancer,2009,NCI,5K07CA125203-02,,Exploring Common Linkage Regions in Lung Cancer and COPD,"COTE, MICHELE",WAYNE STATE UNIVERSITY,MI,"$132,921"
Lung Cancer,2009,NCI,5R01CA115559-05,,Lung Cancer Prognosis: FLT PET and DNA Hypermethylation,"VESSELLE, HUBERT",UNIVERSITY OF WASHINGTON,WA,"$543,475"
Lung Cancer,2009,NCI,5R01CA118200-03,,Management of Breathing effects in Radiotherapy Planning,"BORTFELD, THOMAS",MASSACHUSETTS GENERAL HOSPITAL,MA,"$319,390"
Lung Cancer,2009,NCI,5R01CA120869-03,,DNA Methylation Changes During Development and Progression of Lung Adenocarcinoma,"LAIRD-OFFRINGA, ITE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$299,121"
Lung Cancer,2009,NCRR,5K23RR018784-06,,Prognostic Significance of Actuvated Akt/PKB in Cancer,"DAVID, ODILE",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$120,235"
Lung Cancer,2009,NIEHS,5R01ES014872-04,,Oxidative DNA Lesion Formation from Chromate Exposure,"SUGDEN, KENT",UNIVERSITY OF MONTANA,MT,"$249,607"
Lung Cancer,2009,NIEHS,5R01ES014032-03,,Incident cancer studies in a unique arsenic-exposed area of Chile,"STEINMAUS, CRAIG",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$393,149"
Lung Cancer,2009,NCI,5K22CA123104-02,,The role of EP4 in fibronectin-induced human lung cancer cell growth,"HAN, SHOUWEI",EMORY UNIVERSITY,GA,"$132,412"
Lung Cancer,2009,NCI,5F32CA130376-03,,Let-7 Micro-RNA Therapy to Enhance Radiosensitivity in Lung Cancer Treatment,"TRANG, PHONG",YALE UNIVERSITY,CT,"$55,310"
Lung Cancer,2009,NCI,5R01CA129501-02,,Role of Paxillin in Lung Cancer,"SALGIA, RAVI",UNIVERSITY OF CHICAGO,IL,"$327,175"
Lung Cancer,2009,NIEHS,5R01ES015857-03,,Pathways of PAH activation in human lung cells,"PENNING, TREVOR",UNIVERSITY OF PENNSYLVANIA,PA,"$491,748"
Lung Cancer,2009,NCI,5R01CA124378-11,,Role of Mitotic Checkpoint Defects in Mouse Tumor Models,"BENEZRA, ROBERT",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$295,390"
Lung Cancer,2009,NCI,5K07CA123109-03,,"Bayesian Hierarchical Risk Models: Nutrition, Genes, & Environment Interactions","SWARTZ, MICHAEL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$119,546"
Lung Cancer,2009,NCI,5R01CA092025-08,,Benzo[a]pyrene metabolism: phenotyping and genotyping,"HECHT, STEPHEN",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$338,468"
Lung Cancer,2009,NCRR,5K01RR021879-04,,Regulation of PTHrP in Squamous Cell Carcinoma by the EGF Receptor,"LORCH, GWENDOLEN",OHIO STATE UNIVERSITY,OH,"$126,900"
Lung Cancer,2009,NCI,5K08CA111634-05,,Ras Signaling in Development and Cancer,"SHAW, ALICE",MASSACHUSETTS GENERAL HOSPITAL,MA,"$136,080"
Lung Cancer,2009,NCI,1R01CA139159-01,,Signal Transduction Enzyme Inhibitors from Extremophilic Microbes as Anticancer A,"STIERLE, ANDREA",MONTANA TECH OF THE UNIVOF MONTANA,MT,"$204,868"
Lung Cancer,2009,NCI,5R01CA094188-08,,Oncogenesis By Jaagsiekte Sheep Retrovirus,"FAN, HUNG",UNIVERSITY OF CALIFORNIA IRVINE,CA,"$334,301"
Lung Cancer,2009,NCI,5R01CA092039-06,,GENETICS OF TOBACCO AND ALCOHOL RELATED CANCERS,"BRENNAN, PAUL",INTERNATIONAL AGENCY FOR RES ON CANCER,FR,"$457,747"
Lung Cancer,2009,NCI,5R01CA129533-02,,Molecular Characterization of Stage I Lung Cancer,"YOU, MING",WASHINGTON UNIVERSITY,MO,"$327,529"
Lung Cancer,2009,NCI,5R01CA125256-02,,A lung cancer symptom assessment and management intervention,"COOLEY, MARY",DANA-FARBER CANCER INSTITUTE,MA,"$484,725"
Lung Cancer,2009,NCI,5R01CA121197-03,,High Density Association Analysis of Lung Cancer,"AMOS, CHRISTOPHER",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$568,790"
Lung Cancer,2009,NCI,5R01CA132552-02,,Lung tumor associated macrophages,"MALKINSON, ALVIN",UNIVERSITY OF COLORADO DENVER,CO,"$291,808"
Lung Cancer,2009,NCI,5R01CA113450-02,,Systemic Non-Viral Gene Therapy for Cancer,"RAMESH, RAJAGOPAL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$319,550"
Lung Cancer,2009,NCI,5R01CA125143-03,,Advanced Anatomic and Functional Response Assessment in Lung Cancer,"SCHWARTZ, LAWRENCE",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$355,300"
Lung Cancer,2009,NCI,5R03CA128069-02,,Cytokine Polymorphisms and Cancer Related Pain,"REYES-GIBBY, CIELITO",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$77,000"
Lung Cancer,2009,NCI,5R03CA135661-02,,Diet and second-hand smoke in lung cancer prediction,"FORMAN, MICHELE",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$77,000"
Lung Cancer,2009,NCI,5R01CA129364-02,,Role of EGFR in DNA Repair and Radiation Response in Non Small Cell Lung Cancer,"NIRODI, CHAITANYA",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$260,620"
Lung Cancer,2009,NIBIB,5R21EB008835-02,,"Shape Specific, Enzyme-Responsive, Nano-Imprinted Particles for Drug Delivery","ROY, KRISHNENDU",UNIVERSITY OF TEXAS AUSTIN,TX,"$220,045"
Lung Cancer,2009,NIEHS,5R01ES014399-03,,Genetic Modifiers of Lung Cancer,"WANG, YIAN",WASHINGTON UNIVERSITY,MO,"$335,160"
Lung Cancer,2009,NCI,5R21CA129913-02,,The Role of Memory T-Cells in Pathogenesis,"KISSIL, JOSEPH",WISTAR INSTITUTE,PA,"$181,939"
Lung Cancer,2009,NCI,5R01CA080127-09,,Alpha-1 AD Carriers and Lung Cancer Risk,"YANG, PING","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$451,218"
Lung Cancer,2009,NCI,5R01CA115857-04,,Health and QOL among Long-Term Lung Cancer Survivors,"YANG, PING","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$484,323"
Lung Cancer,2009,NCI,5R01CA134541-02,,INCORPORATING REAL-TIME LOCALIZATION  IN RADIATION THERAPY PLANNING AND DELIVERY,"PARIKH, PARAG",WASHINGTON UNIVERSITY,MO,"$279,013"
Lung Cancer,2009,NCI,5K24CA120494-03,,K24 Mid-Career Investigator Award in Patient-Oriented Research,"SILVESTRI, GERARD",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$144,531"
Lung Cancer,2009,NCI,5R21CA132109-02,,Inflammatory Cytokines Associated Symptom Burden in NSCLC Patients Receiving CXRT,"WANG, XIN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$173,250"
Lung Cancer,2009,NCI,5R01CA126993-02,,Respiratory Motion-Reduced Cone-Beam CT Guidance of Radiotherapy in Lung & Liver,"MAGERAS, GIKAS",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$496,047"
Lung Cancer,2009,NCI,5R03CA132145-02,,Multiplex approach to DNA methylation assays in exhaled breath condensate,"HAN, WEIGUO",ALBERT EINSTEIN COL OF MED YESHIVA UNIV,NY,"$83,000"
Lung Cancer,2009,NCI,5K23CA122182-02,,Radioguided Detection of Lymph Node Metastasis in Non-Small Cell Lung Cancer,"NWOGU, CHUKWUMERE",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$148,505"
Lung Cancer,2009,NCI,5R01CA116812-02,,Lung extracellular matrix and tumor progression,"ROMAN, JESSE",EMORY UNIVERSITY,GA,"$321,625"
Lung Cancer,2009,NCI,5R01CA124490-03,,Role of Nicotine in Lung Carcinogenesis,"CHEN, CHANGYAN",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$323,000"
Lung Cancer,2009,NCI,2R01CA039504-23,,Aldo-Keto Reductases and PAH Metabolism/Activation,"PENNING, TREVOR",UNIVERSITY OF PENNSYLVANIA,PA,"$289,179"
Lung Cancer,2009,NCI,5R01CA102792-07,,Use of Beta-lapachone for Lung Cancer Chemotherapy,"BOOTHMAN, DAVID",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$341,159"
Lung Cancer,2009,NCI,1R01CA131261-01A2,,"Studying the initiation, progression and therapy of lung cancer in mouse models","MCMAHON, MARTIN",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$345,416"
Lung Cancer,2009,NCI,1R01CA124495-01A2,,The Role of RAC1 in Cancer,"KISSIL, JOSEPH",WISTAR INSTITUTE,PA,"$347,148"
Lung Cancer,2009,NCI,1R01CA136635-01A1,,ROLE OF DNA METHYLTRANSFERASE 3B IN LUNG TUMORIGENESIS,"MAO, LI",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$311,250"
Lung Cancer,2009,NCI,2R01CA096679-05A2,,LUNG TRAJECTORY MAPPING FOR RADIATION THERAPY,"LOW, DANIEL",WASHINGTON UNIVERSITY,MO,"$306,143"
Lung Cancer,2009,NCI,5R01CA129011-02,,Ultra-Sensitive MR Probes for Molecular Diagnosis of Lung Cancer,"GAO, JINMING",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$325,775"
Lung Cancer,2009,NCI,2R01CA092824-07,,Molecular and Genetic Analysis of Lung Cancer Survival,"CHRISTIANI, DAVID",HARVARD UNIVERSITY (SCH OF PUBLIC HLTH),MA,"$576,794"
Lung Cancer,2009,NCI,5K01CA128823-03,,Folate Metabolism & Methylation in Lung Cancer,"FLORES, KRISTINA",UNIVERSITY OF NEW MEXICO,NM,"$136,894"
Lung Cancer,2009,NCI,5R01CA125653-03,,Circulating Tumor Cells in Non-Small Cell Lung Cancer,"NIEVA, JORGE",BILLINGS CLINIC FOUNDATION,MT,"$337,278"
Lung Cancer,2009,NCI,1R21CA130349-01A2,,Telemere Targeted Therapy in Lung Cancer,"EDELMAN, MARTIN",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$269,933"
Lung Cancer,2009,NIEHS,5F30ES015669-03,,Prevention of Head and Neck Carcinogenesis with a Plant-Derived Compound,"LEEMAN, REBECCA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$46,176"
Lung Cancer,2009,NCI,7R01CA126818-02,,HDGF: a novel biomarker and therapetic target of lung cancer,"MAO, LI",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$311,250"
Lung Cancer,2009,NCI,5R01CA123208-04,,Chromosomal Aberrations and Risk for Familial Lung Cancer,"ETZEL, CAROL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$272,220"
Lung Cancer,2009,NCI,5R01CA135257-02,,Drug Resistance in Lung Cancer,"JANNE, PASI",DANA-FARBER CANCER INSTITUTE,MA,"$358,976"
Lung Cancer,2009,NCI,5R01CA131044-02,,NIR Imaging of Sentinel Nodes in Lung Cancer: Finding Micrometastases,"COLSON, YOLONDA",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$360,853"
Lung Cancer,2009,NCI,5R01CA116249-04,,Image Guided Integrated Active Breath Hold Radiotherapy,"HUGO, GEOFFREY",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$192,961"
Lung Cancer,2009,NCI,2K05CA092002-06A2,,Mentoring and Research in Cancer Epidemiology,"WEISS, NOEL",UNIVERSITY OF WASHINGTON,WA,"$156,254"
Lung Cancer,2009,NCCAM,1R21AT004503-01A2,,Anti-carcinogenic effects of White Tea on Lung Cancer,"MAO, JENNY",BIOMEDICAL RESEARCH INSTITUTE OF NEW MEX,NM,"$162,624"
Lung Cancer,2009,NCI,5R01CA124967-03,,High Resolution Optical Coherence Tomography for Early Airway Cancer Detection,"BRENNER, MATTHEW",UNIVERSITY OF CALIFORNIA IRVINE,CA,"$260,775"
Lung Cancer,2009,NCI,5R01CA076354-09,,A mouse model of stem cell deregulation and lung cancer,"LOCKER, JOSEPH",ALBERT EINSTEIN COL OF MED YESHIVA UNIV,NY,"$264,921"
Lung Cancer,2009,NCI,1R03CA135701-01A1,,Groundwork for a study of non-smoking-associated lung cancer in AsianPacific Isla,"CHANG, ELLEN",NORTHERN CALIFORNIA CANCER CENTER,CA,"$72,500"
Lung Cancer,2009,NCI,5R01CA111703-04,,MOLECULAR EPIDEMIOLOGY OF LUNG CANCER,"CHEN, CHU",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$165,522"
Lung Cancer,2009,NIA,5K08AG031583-02,,Continuity of care and end of the life ICU use,"SHARMA, GULSHAN",UNIVERSITY OF TEXAS MEDICAL BR GALVESTON,TX,"$119,610"
Lung Cancer,2009,NHLBI,5R01HL054853-14,,Electrophil elastase in lung cancer and COPD,"SHAPIRO, STEVEN",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$360,484"
Lung Cancer,2009,NCI,5R01CA120188-03,,"Integrin avb3 targeted drug design, delivery, and imaging","NEAMATI, NOURI",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$213,984"
Lung Cancer,2009,NCI,5R01CA121922-03,,Young Smoker's Reactions to Genetic Risk for Lung Cancer,"LIPKUS, ISAAC",DUKE UNIVERSITY,NC,"$251,910"
Lung Cancer,2009,NCI,5R01CA068377-13,,The Physiological Function and Regulation of INK4 Genes,"XIONG, YUE",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$320,372"
Lung Cancer,2009,NCI,5K01CA124581-03,,Racial disparities in the treatment of lung cancer in African Americans,"LATHAN, CHRISTOPHER",DANA-FARBER CANCER INSTITUTE,MA,"$139,167"
Lung Cancer,2009,NCI,5R01CA133996-03,,Statistical Methods for Gene Environment Interactions In Lung Cancer,"AMOS, CHRISTOPHER",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$263,340"
Lung Cancer,2009,NHLBI,5K08HL085286-04,,"Interrelationships Between COPD, Inflammation, and Lung Tumorigenesis","HOUGHTON, A",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$126,225"
Lung Cancer,2009,NCI,5K08CA114176-05,,Imaging Lung Cancer in Mice To Improve Radiation Therapy,"KIRSCH, DAVID",DUKE UNIVERSITY,NC,"$130,329"
Lung Cancer,2009,NCI,5R01CA061021-16,,Effect of Tobacco Advocacy at the State Level,"GLANTZ, STANTON",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$388,337"
Lung Cancer,2009,NCI,5R21CA121068-02,,Exhaled Breath DNA Methylation in Lung Carcinogenesis,"SPIVACK, SIMON",ALBERT EINSTEIN COL OF MED YESHIVA UNIV,NY,"$186,817"
Lung Cancer,2009,NCI,7R01CA127636-03,,Impact of BRG1 Loss in Lung Cancer Development,"REISMAN, DAVID",UNIVERSITY OF FLORIDA,FL,"$278,350"
Lung Cancer,2009,NCI,5R01CA088932-08,,Regulation of Telomerase by Ceramide in Lung Cancer,"OGRETMEN, BESIM",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$207,232"
Lung Cancer,2009,NCI,5U01CA097432-08,,Modeling Interventions for Lung Cancer Mortality,"HOLFORD, THEODORE",YALE UNIVERSITY,CT,"$245,948"
Lung Cancer,2009,NCI,5R01CA125447-03,,Evaluating the Effectiveness of Lung Cancer Treatment in the Elderly,"WISNIVESKY, JUAN",MOUNT SINAI SCHOOL OF MEDICINE OF NYU,NY,"$203,400"
Lung Cancer,2009,NCI,5U01CA097450-08,,"A Simulation of Tobacco Policy, Smoking and Lung Cancer","LEVY, DAVID",PACIFIC INSTITUTE FOR RES AND EVALUATION,MD,"$219,177"
Lung Cancer,2009,NCI,5R33CA127055-03,,CHFR Methylation for Predicting Taxane Sensitivity in Lung and Esophageal Cancer,"HERMAN, JAMES",JOHNS HOPKINS UNIVERSITY,MD,"$270,600"
Lung Cancer,2009,NCI,5R01CA129610-02,,Mechanism and role of DLC-1 tumor suppressor loss in lung cancer,"DER, CHANNING",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$305,763"
Lung Cancer,2009,NCI,5R01CA120247-04,,Mutant EGF Receptor-Dependent Lung Cancer in Human Cell Lines and Transgenic Mice,"VARMUS, HAROLD",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$493,144"
Lung Cancer,2009,NCI,5R01CA129632-03,,microRNA regulation of drug sensitivity in non-small cell lung cancer,"PERTSEMLIDIS, ALEXANDER",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$266,304"
Lung Cancer,2009,NCI,5K07CA111952-04,,Molecular epidemiology of lung cancer,"VACHANI, ANIL",UNIVERSITY OF PENNSYLVANIA,PA,"$138,429"
Lung Cancer,2009,NCI,5R21CA135382-02,,A Sensitive and Automated Diagnostic Assay for Lung Cancer,"JIANG, FENG",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$168,750"
Lung Cancer,2009,NCI,5R01CA129022-03,,Precise Correspondence of 3D Pathology with Radiological Features in Lung Nodules,"MCLENNAN, GEOFFREY",UNIVERSITY OF IOWA,IA,"$346,326"
Lung Cancer,2009,NCI,5K01CA123355-03,,Using Tobacco Biomarkers to Improve Smoking Cessation Rates,"WILSON, STEPHEN",UNIVERSITY OF CINCINNATI,OH,"$136,890"
Lung Cancer,2009,NCI,1R43CA139729-01,,MULTI-TARGETED RNAI THERAPEUTICS FOR TREATMENT OF LUNG CANCER (NSCLC),"LU, PATRICK","SIRNAOMICS, INC.",MD,"$250,000"
Lung Cancer,2009,NHLBI,5R01HL090483-03,,The Study of HIV Infection in the Etiology of Lung Disease (SHIELD),"KIRK, GREGORY",JOHNS HOPKINS UNIVERSITY,MD,"$889,680"
Lung Cancer,2009,NIEHS,5R03ES016888-02,,Roles of Claudin-7 in Lung Cancer,"CHEN, YAN-HUA",EAST CAROLINA UNIVERSITY,NC,"$71,750"
Lung Cancer,2009,NCI,1R43CA139790-01,,Development of Probodies: A Novel Class of Therapeutic Antibodies Combining Targe,"WEST, JAMES","CYTOMX THERAPEUTICS, LLC",CA,"$260,910"
Lung Cancer,2009,NCI,1R43CA139806-01,,Autoantibody Profiling for Serological Detection of Head and Neck Cancer,"KHATTAR, NADA","20/20 GENESYSTEMS, INC.",MD,"$217,801"
Lung Cancer,2009,NIBIB,5R37EB000244-30,,Controlled Release of Macromolecules,"LANGER, ROBERT",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$406,614"
Lung Cancer,2009,NIA,5F30AG030298-03,,The Contribution of Chronic Inflammation to Pulmonary Adenocarcinoma,"DOUGAN, MICHAEL",HARVARD UNIVERSITY (MEDICAL SCHOOL),MA,"$46,176"
Lung Cancer,2009,NCI,5U01CA097415-08,,Lung Cancer in the U.S.: Trends and Prevention,"MOOLGAVKAR, SURESH",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$221,387"
Lung Cancer,2009,NCI,5R21CA138277-02,,Ginger Extract: Bioavailability Study and Lung Cancer Preventive Effect,"SANG, SHENGMIN",NORTH CAROLINA CENTRAL UNIVERSITY,NC,"$140,884"
Lung Cancer,2009,NINR,1F31NR011261-01,,A Study of Medication Taking for NSCLC Patients Receiving Oral Targeted Therapy,"WICKERSHAM, KAREN",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$41,176"
Lung Cancer,2009,NCI,5R21CA130849-02,,Lung Tumor Motion Behavior Analysis Using 4DCT,"WU, HUANMEI",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$172,938"
Lung Cancer,2009,NCI,5R01CA135358-02,,Targeted liposomal radiotherapy of malignant mesothelioma,"HE, JIANG",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$259,491"
Lung Cancer,2009,NIBIB,5R01EB008047-03,,Point-of-Care Microfluidics in Lung Cancer,"TONER, MEHMET",MASSACHUSETTS GENERAL HOSPITAL,MA,"$1,114,356"
Lung Cancer,2009,NCI,5K24CA128953-02,,Development of Immunotherapeutic Strategies in the Treatment of Lung Cancer,"ANTONIA, SCOTT",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$164,476"
Lung Cancer,2009,NCI,1R03CA139862-01,,Psychosocial Support Needs and Preferences of Caregivers of Lung Cancer Patients,"MOSHER, CATHERINE",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$94,800"
Lung Cancer,2009,NCI,5R01CA131348-02,,Prognosis and Effectiveness of Advanced Lung Cancer Treatment in the Elderly,"WISNIVESKY, JUAN",MOUNT SINAI SCHOOL OF MEDICINE OF NYU,NY,"$258,064"
Lung Cancer,2009,NCCAM,5R01AT003203-03,,Chemoprevention of Lung Cancer with Anti-tumor B,"YOU, MING",WASHINGTON UNIVERSITY,MO,"$368,725"
Lung Cancer,2009,NIEHS,5F32ES016683-03,,Defining PAH-mediated carcinogenesis in lung: CYP metabolism and B[a]P transport,"GELHAUS, STACY",UNIVERSITY OF PENNSYLVANIA,PA,"$51,710"
Lung Cancer,2009,NCI,5R21CA121582-02,,MR-predictive-assay in pre-operative lung cancer therapy: response/resectability,"GRECULA, JOHN",OHIO STATE UNIVERSITY,OH,"$337,500"
Lung Cancer,2009,NCI,5U01CA076293-10,,Genetic Epidemiology of Lung Cancer,"ANDERSON, MARSHALL",UNIVERSITY OF CINCINNATI,OH,"$982,565"
Lung Cancer,2009,NCI,5K99CA134920-02,,Optical Imaging of the Pulmonary Airways in the Assessment of Lung Cancer,"SUTER, MELISSA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$142,560"
Lung Cancer,2009,NCI,5K99CA131488-02,,Mechanisms of Mutant Epidermal Growth Factor Receptor Induced Lung Tumorigenesis,"POLITI, KATERINA",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$139,296"
Lung Cancer,2009,NCI,5K99CA131477-02,,UDP-glucuronosyltransferase genes and gender-differences in lung cancer risk,"GALLAGHER, CARLA",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$136,566"
Lung Cancer,2009,NCI,5U01CA097431-08,,"Lung Cancer Model: Risk, Progression and Intervention","KIMMEL, MAREK",RICE UNIVERSITY,TX,"$220,817"
Lung Cancer,2009,NCI,5K01CA125204-04,,Improving Effectiveness and Accuracy of Radiation Therapy,"HOWELL, REBECCA",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$133,622"
Lung Cancer,2009,NCI,5R21CA128628-02,,Development of methodologies for the analysis of DNA repair capacity to predict t,"TURCHI, JOHN",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$204,156"
Lung Cancer,2009,NCI,5U01CA111219-05,,DNA Repair Biomarkers for Cancer Risk Assessment and Ea*,"LIVNEH, ZVI",WEIZMANN INSTITUTE OF SCIENCE,ISRAEL,"$149,921"
Lung Cancer,2009,NCI,5R01CA121144-02,,Chemoresistance and Motility: Role of Mutant p53 and NF-kB2 in Cancer,"DEB, SUMITRA",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$248,170"
Lung Cancer,2009,NCI,5R01CA095039-06,,Sequence distribution of tobacco carcinogen-DNA adducts,"TRETYAKOVA, NATALIA",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$210,520"
Lung Cancer,2009,NCI,5K23CA115908-04,,Symptom Management Trial in Cancer Survivors,"PIRL, WILLIAM",MASSACHUSETTS GENERAL HOSPITAL,MA,"$141,345"
Lung Cancer,2009,NCI,5R01CA127547-02,,Identification and characterization of driver gene(s) in recurrent lung cancer am,"MU, DAVID",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$289,649"
Lung Cancer,2009,NCI,5R01CA119029-04,,Development of DNA Methylation Markers for Early Detection of Lung Cancer,"LAIRD-OFFRINGA, ITE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$288,570"
Lung Cancer,2009,NCI,5R21CA135595-02,,A randomized phase II study of erlotinib with or without the anti-IGF-1R monoclon,"CAMIDGE, ROSS",UNIVERSITY OF COLORADO DENVER,CO,"$348,354"
Lung Cancer,2009,NCI,5R01CA118434-02,,Biochemical Mechanisms of Se Anticancer Activity in Lung,"FAN, TERESA",UNIVERSITY OF LOUISVILLE,KY,"$307,100"
Lung Cancer,2009,NCI,5U01CA097416-09,,SURVEILLANCE OF LUNG CANCER TRENDS IN THE US WITH MISCAN,"DE KONING, HARRY",ERASMUS MEDICAL CENTER,NETH,"$114,534"
Lung Cancer,2009,NIEHS,5R01ES016284-02,,BIOMARKERS OF EXPOSURE AND EFFECT IN A TRAFFIC EXPOSED POPULATION,"LADEN, FRANCINE",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$740,127"
Lung Cancer,2009,NCI,5R01CA135405-02,,Transition State Analogues as Modulators of DNA Methylation,"SCHRAMM, VERN",ALBERT EINSTEIN COL OF MED YESHIVA UNIV,NY,"$270,000"
Lung Cancer,2009,NCI,5R03CA137742-02,,Magnetic Enrichment for Genetic Detection of Carcinoma Cells in Sputum,"JIANG, FENG",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$75,000"
Lung Cancer,2009,NCI,5R03CA137796-02,,Lung Cancer Chemoprevention through LC-1,"NAKSHATRI, HARIKRISHNA",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$77,000"
Lung Cancer,2009,NCI,7R03CA128038-02,,"BRM promoter polymorphism, a marker for cancer risks","REISMAN, DAVID",UNIVERSITY OF FLORIDA,FL,"$73,250"
Lung Cancer,2009,NIEHS,5R01ES015262-02,,Genetic and Epigenetic Biomarkers for SCC of the Lung,"BELINSKY, STEVEN",LOVELACE BIOMEDICAL & ENVIRONMENTAL RES,NM,"$671,875"
Lung Cancer,2009,NCI,5R43CA137952-02,,In vivo RNAi nanoparticle cancer gene function reagent,"WOODLE, MARTIN",APARNA BIOSCIENCES CORPORATION,MD,"$235,400"
Lung Cancer,2009,NCI,5R44CA114802-03,,MAb-based targeted chemotherapy of lung cancer,"GOVINDAN, SERENGULAM","IMMUNOMEDICS, INC.",NJ,"$239,702"
Lung Cancer,2009,NCI,5R01CA116648-04,,Validating Molecular Signature Risk Models of NSCLC,"HARPOLE, DAVID",DUKE UNIVERSITY,NC,"$455,257"
Lung Cancer,2009,NHLBI,5R21HL091310-02,,Sleep disorders and QOL in lung cancer survivors,"GOONERATNE, NALAKA",UNIVERSITY OF PENNSYLVANIA,PA,"$196,875"
Lung Cancer,2009,NCI,5R01CA100750-06,,Role of c-Met in SCLC and Potential for Novel Therapy,"SALGIA, RAVI",UNIVERSITY OF CHICAGO,IL,"$251,380"
Lung Cancer,2009,NCI,5R03CA130067-02,,Disparities in Lung and Colorectal Cancers,"BOEHMER, ULRIKE",BOSTON UNIVERSITY MEDICAL CAMPUS,MA,"$81,250"
Lung Cancer,2009,NCI,5K23CA106544-06,,Pulmonary rehabilitation before lung cancer resection.,"BENZO, ROBERTO","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$133,650"
Lung Cancer,2009,NCI,5R01CA138256-02,,Comparative functional genomics for lung cancer gene discovery,"SWEET-CORDERO, ERIC",STANFORD UNIVERSITY,CA,"$573,992"
Lung Cancer,2009,NCI,5K08CA131483-02,,TGFbeta and lung squamous cell carcinoma,"MALKOSKI, STEPHEN",UNIVERSITY OF COLORADO DENVER,CO,"$136,900"
Lung Cancer,2009,NCI,1R33CA140039-01,,A multiplex genome-wide shRNA screening platform for cancer-lethal gene discovery,"ELLEDGE, STEPHEN",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$361,095"
Lung Cancer,2009,NCI,5R01CA133470-02,,Secoisolariciresinol Diglucoside (SDB) Protection in Radiation Pheumonopathy,"CHRISTOFIDOU-SOLOMIDOU, MELPO",UNIVERSITY OF PENNSYLVANIA,PA,"$319,654"
Lung Cancer,2009,NCI,5R44CA125999-03,,Brachytherapy Delivery System for Treatment of Lung Cancer,"MUNRO, JOHN",SOURCE PRODUCTION AND EQUIPMENT COMPANY,LA,"$378,540"
Lung Cancer,2009,NCI,5R21CA129050-02,,Cytokinesis-blocked micronucleus assay: a predictive biomarker of lung cancer ris,"EL-ZEIN, RANDA",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$138,600"
Lung Cancer,2009,NCI,5R03CA133885-02,,Tobacco Smoke Sensitive Genes and Genetic Susceptibility to Small-Cell Lung Cance,"GORLOV, IVAN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$77,000"
Lung Cancer,2009,NCI,5F32CA136148-02,,Short-Interfering RNA-Gold Nanoparticle Bioconjugates:  A New Cancer Therapy,"BRAUNSCHWEIG, ADAM",NORTHWESTERN UNIVERSITY,IL,"$51,710"
Lung Cancer,2009,NCI,5F31CA136161-02,,Identifying a Cancer Stem Cell Population in Non-Small Cell Lung Carcinoma,"OSANYINGBEMI, JOYCE",JOHNS HOPKINS UNIVERSITY,MD,"$41,176"
Lung Cancer,2009,NCI,1R01CA140991-01,,Targeting Glucose Metabolism in Cancer,"TELANG, SUCHETA",UNIVERSITY OF LOUISVILLE,KY,"$245,680"
Lung Cancer,2009,NCI,2R01CA105155-06A1,,Kinase Signaling in Lung Tumorigenesis,"KURIE, JONATHAN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$251,447"
Lung Cancer,2009,NIDA,1R21DA026918-01,,Function of the CHRNA5 D398N SNP:  implications for addiction and lung cancer ris,"STITZEL, JERRY",UNIVERSITY OF COLORADO AT BOULDER,CO,"$467,458"
Lung Cancer,2009,NIEHS,1R21ES017494-01,,Developing a murine model for arsenic-induced skin neoplasm,"ATHAR, MOHAMMAD",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$219,563"
Lung Cancer,2009,NCI,1K99CA140792-01,,Mutant Epidermal Growth Factor Receptor Signaling in Lung Cancer,"GUHA, UDAYAN",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$165,229"
Lung Cancer,2009,NCI,1R01CA132847-01A2,,Role and mechanism of action of p62/Sqstm1 in Ras-induced tumorigenesis in lung,"MOSCAT, JORGE",UNIVERSITY OF CINCINNATI,OH,"$333,036"
Lung Cancer,2009,NCI,1R01CA129534-01A2,,Biomarkers of NNK in prediction of lung cancer development in smokers,"YUAN, JIAN-MIN",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$582,501"
Lung Cancer,2009,NCI,2R01CA101880-05A2,,Novel DNA-metalating Hybrid Anticancer Agents,"BIERBACH, ULRICH",WAKE FOREST UNIVERSITY,NC,"$229,541"
Lung Cancer,2009,NCI,2R01CA106314-06A1,,Dmp1-p53/YY1 interplays and their roles in lung cancer development,"INOUE, KAZUSHI",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$266,677"
Lung Cancer,2009,NIEHS,1R01ES016893-01A1,,Particulate Cr(VI) Toxicology in Human Lung Epithelial Cells and Fibroblasts,"WISE, JOHN",UNIVERSITY OF SOUTHERN MAINE,ME,"$305,262"
Lung Cancer,2009,NCI,1R01CA136705-01A1,,Epigenetic and post-translational regulation of the metastasis suppressor BRMS1,"JONES, DAVID",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$300,684"
Lung Cancer,2009,NCI,1R01CA134433-01A2,,MOLECULAR GENETICS OF LUNG TUMOR PROMOTION IN MICE,"YOU, MING",WASHINGTON UNIVERSITY,MO,"$315,400"
Lung Cancer,2009,NCI,1R01CA134682-01A2,,Genome-Wide Association Studies of Inherited Predisposition to Lung Cancer,"YOU, MING",WASHINGTON UNIVERSITY,MO,"$442,652"
Lung Cancer,2009,NCI,1R01CA136910-01A1,,Effects of Low Dose CT Radiation on Lung Tumorigenesis,"MUNLEY, MICHAEL",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$451,410"
Lung Cancer,2009,NCI,1R21CA135608-01A2,,Phase I Trial with Two HER-2 B Cell Epitope Vaccine in Patients with Solid Tumors,"KAUMAYA, PRAVIN",OHIO STATE UNIVERSITY,OH,"$330,000"
Lung Cancer,2009,NCI,1R03CA136054-01A1,,The Daily Experience of Somatic Anxiety and Worry in Lung Cancer Survivors,"ARONSON, KEITH",PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,PA,"$76,033"
Lung Cancer,2009,NCI,2R01CA100816-05,,Novel Strategy for Lung Cancer Treatment Using IGF-1R Inhibitor,"LEE, HO-YOUNG",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$251,447"
Lung Cancer,2009,NCI,1K08CA137170-01A1,,Role of Bronchioalveolar Stem Cells in Tissue Repair and Lung Adenocarcinomas,"KUMAR, ATUL",STANFORD UNIVERSITY,CA,"$145,238"
Lung Cancer,2009,NCI,1R01CA138624-01A1,,Phase III Trial of Exercise Training in Postsurgical Lung Cancer,"JONES, LEE",DUKE UNIVERSITY,NC,"$469,128"
Lung Cancer,2009,NCI,2U01CA084306-11,,Integrative genomic characterization of lung cancer metastasis in mouse and human,"JACKS, TYLER",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$773,385"
Lung Cancer,2009,NCI,1K01CA128887-01A2,,The Role of MicroRNAs in Controlling Fibroblast Proliferation and Tumor Promotion,"LEGESSE-MILLER, ASTER",PRINCETON UNIVERSITY,NJ,"$115,801"
Lung Cancer,2009,RMAP,1R21NS066482-01,,Development of HTS assays for Bcl-2 converters,"SATTERTHWAIT, ARNOLD",BURNHAM INSTITUTE FOR MEDICAL RESEARCH,CA,"$191,000"
Lung Cancer,2009,NCI,1R01CA134503-01A2,,Notch-1 and IGF-1 crosstalk: new therapeutic strategies for NSCLC,"BOCCHETTA, MAURIZIO",LOYOLA UNIVERSITY CHICAGO,IL,"$295,833"
Lung Cancer,2009,NCI,1R01CA136765-01A1,,Genetic determinants associated with pemetrexed response and toxicity,"DOLAN, M",UNIVERSITY OF CHICAGO,IL,"$341,638"
Lung Cancer,2009,NIEHS,2R01ES008786-12A1,,Genotoxicity of Chromium Compounds,"ZHITKOVICH, ANATOLY",BROWN UNIVERSITY,RI,"$363,094"
Lung Cancer,2009,NIEHS,1R21ES017307-01A1,,Allergic asthma and chromium exposure,"CONSTANT, STEPHANIE",GEORGE WASHINGTON UNIVERSITY,DC,"$234,750"
Lung Cancer,2009,NCI,1R01CA141716-01,,Genetic Susceptibility for Lung Cancer in African Americans,"AMOS, CHRISTOPHER",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$397,997"
Lung Cancer,2009,NCI,1R43CA141786-01,,Identification of microRNA Biomarkers for Lung Cancer,"MAMBO, ELIZABETH","AMBION DIAGNOSTICS, INC.",TX,"$273,456"
Lung Cancer,2009,NCI,3R01CA107972-05S1,,Survival Signaling After Genotoxic Insult,"CERYAK, SUSAN",GEORGE WASHINGTON UNIVERSITY,DC,"$33,089"
Lung Cancer,2009,NCI,1R41CA141907-01,,Bronchio-adventitial Drug Delivery: Paclitaxel for Bronchial Carcinoma,"SEWARD, KIRK","MERCATOR MEDSYSTEMS, INC.",CA,"$218,055"
Lung Cancer,2009,NCI,1R44CA139803-01A1,,Field of Injury Based Biomarkers for Lung Cancer,"BRODY, JEROME","ALLEGRO DIAGNOSTICS, INC.",MA,"$277,875"
Lung Cancer,2009,NCI,1R43CA141963-01,,Profiling Autoantibodies in Non-small Cell Lung Cancer with Fusion Protein-Peptid,"KHATTAR, NADA","20/20 GENESYSTEMS, INC.",MD,"$183,927"
Lung Cancer,2009,NCI,2R44CA121612-02A1,,New Cancer Vaccine Technology Based on DRibbles Produced by Tumor Cells,"AUNG, SANDRA","UBIVAC, LLC",OR,"$760,163"
Lung Cancer,2009,NCCAM,1F31AT005041-01A1,,Redox Mechanisms of Chemoprevention in Lung by Selenium Supplementation,"POERSCHKE, ROBYN",UNIVERSITY OF UTAH,UT,"$31,653"
Lung Cancer,2009,NCI,1R03CA141998-01,,A Novel Bayesian Model Averaging Approach for Genome Wide Association Studies,"SWARTZ, MICHAEL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$77,000"
Lung Cancer,2009,NCI,1F32CA142039-01,,Lung squamous cell carcinoma subtypes: genomic abberations and clinical detection,"WILKERSON, MATTHEW",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$48,752"
Lung Cancer,2009,NIEHS,1F30ES017730-01,,Y-family DNA polymerases and cellular responses to benzo[a]pyrene,"KLARER, ALDEN",UNIVERSITY OF LOUISVILLE,KY,"$31,991"
Lung Cancer,2009,NCI,4R00CA128926-02,,Harnessing Functional Genomics to Reveal Cancer Specific Determinants of Mitosis,"WHITEHURST, ANGELIQUE",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$249,000"
Lung Cancer,2009,NCI,1R03CA137819-01A1,,ROLE OF AP-1 IN THE CHEMOPREVENTIVE FUNCTION OF GREEN TEA IN VIVO,"TICHELAAR, JAY",WASHINGTON UNIVERSITY,MO,"$76,000"
Lung Cancer,2009,NCI,1R03CA142075-01,,Development of a blood-based mircroRNA profile as a biomarker for lung cancer,"PATNAIK, SANTOSH",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$63,255"
Lung Cancer,2009,NCI,1F31CA142164-01,,Mechanisms of Lung Cancer,"TORMOS, KATHRYN",NORTHWESTERN UNIVERSITY,IL,"$28,036"
Lung Cancer,2009,NCI,3R01CA111851-04S1,,Novel COX-2 and PGE2-dependent pathways in lung cancer,"DUBINETT, STEVEN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$58,710"
Lung Cancer,2009,NCI,5P30CA046934-22,0010,TOBACCO RELATED MALIGNANCIES,"MILLER, YORK",UNIVERSITY OF COLORADO DENVER,CO,"$26,169"
Lung Cancer,2009,NCCAM,1R01AT005522-01,,Chemoprevention of lung cancer with red ginseng extracts,"YOU, MING",WASHINGTON UNIVERSITY,MO,"$312,870"
Lung Cancer,2009,OD,1R01AT005522-01,,Chemoprevention of lung cancer with red ginseng extracts,"YOU, MING",WASHINGTON UNIVERSITY,MO,"$200,000"
Lung Cancer,2009,NCI,1R01CA133539-01A2,,Radiotherapy with Dose-Rate Regulated Tracking,"YI, BYONGYONG",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$360,952"
Lung Cancer,2009,NCI,1R01CA131217-01A2,,Nonpeptide macrocyclic histone deacetylase (HDAC) inhibitors for targeted lung ca,"OYELERE, ADEGBOYEGA",GEORGIA INSTITUTE OF TECHNOLOGY,GA,"$295,452"
Lung Cancer,2009,NCI,1K07CA138772-01A1,,Improving decisions about evaluating pulmonary nodules for lung cancer,"WIENER, RENDA",DARTMOUTH COLLEGE,NH,"$182,974"
Lung Cancer,2009,NIEHS,5P42ES004705-22,0016,Project 3: Arsenic Biomarker Epidemiology,"SMITH, ALLAN",UNIVERSITY OF CALIFORNIA BERKELEY,CA,"$410,861"
Lung Cancer,2009,NCI,1R03CA143999-01,,ISC-4 as a Novel Lung Cancer Chemopreventive Agent,"SHARMA, ARUN",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$76,353"
Lung Cancer,2009,NIEHS,5P30ES013508-04,9003,CORE--Lung and Airway Disease,"PANETTIERI, REYNOLD",UNIVERSITY OF PENNSYLVANIA,PA,"$102,758"
Lung Cancer,2009,NIEHS,5P42ES010349-09,0003,Project 2: Health Effects of As Cohort Study,"AHSAN, HABIBUL",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$695,078"
Lung Cancer,2009,NCI,5P50CA090949-08,0001,CROSS CULTURAL STUDY OF LUNG CANCER RISK AND INFLAMMATORY PATHWAY SNPS,"CAI, QIUYIN",VANDERBILT UNIVERSITY,TN,"$322,858"
Lung Cancer,2009,NCI,5P50CA090949-08,0002,MOLECULAR SIGNATURES OF NSCLC,"MASSION, PIERRE",VANDERBILT UNIVERSITY,TN,"$379,496"
Lung Cancer,2009,NCI,5P50CA090949-08,0003,EICOSANOID PATHWAY TARGETS IN LUNG CANCER,"JOHNSON, DAVID",VANDERBILT UNIVERSITY,TN,"$220,309"
Lung Cancer,2009,NCI,5P50CA090949-08,0004,TARGETING NOTCH 3 IN LUNG CANCER,"DANG, THAO",VANDERBILT UNIVERSITY,TN,"$212,322"
Lung Cancer,2009,NCI,5P50CA090949-08,0005,TARGETING HISTONE DEACETYLASES IN NSCLC,"DATTA, PRAN",VANDERBILT UNIVERSITY,TN,"$229,309"
Lung Cancer,2009,NCI,5P50CA090949-08,0006,DEVELOPMENTAL RESEARCH PROGRAM,"CARBONE, DAVID",VANDERBILT UNIVERSITY,TN,"$70,133"
Lung Cancer,2009,NCI,5P50CA090949-08,0007,CAREER DEVELOPMENT PROGRAM,"CARBONE, DAVID",VANDERBILT UNIVERSITY,TN,"$210,414"
Lung Cancer,2009,NCI,5P50CA090949-08,9001,PATHOLOGY AND TISSUE RESOURCES CORE,"GONZALEZ, ADRIANA",VANDERBILT UNIVERSITY,TN,"$334,228"
Lung Cancer,2009,NCI,5P50CA090949-08,9002,CLINICAL CORE,"SANDLER, ALAN",VANDERBILT UNIVERSITY,TN,"$115,992"
Lung Cancer,2009,NCI,5P50CA090949-08,9003,BIOSTATISTICS CORE,"SHYR, YU",VANDERBILT UNIVERSITY,TN,"$204,939"
Lung Cancer,2009,NCI,5P50CA086306-10,0007,Metabolic Phenotyping with PET to Monitor and Predict Response to Kinase,"CZERNIN, JOHANNES",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$257,338"
Lung Cancer,2009,NCI,5P01CA116602-03,0004,Four-dimensional Adaptive Thoracic Radiotherapy,"KEALL, PAUL",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$305,161"
Lung Cancer,2009,NCI,5P50CA058187-15,0018,SEMA3F and ZEB1 in Lung Cancer: Therapy and Target Gene Discovery,"DRABKIN, HARRY",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$407,604"
Lung Cancer,2009,NCI,5P50CA058187-15,0019,Growth Factor Inhibitors for Lung Cancer Therapy and Prevention,"BUNN, PAUL",UNIVERSITY OF COLORADO DENVER,CO,"$298,681"
Lung Cancer,2009,NCI,5P50CA058187-15,0020,Prostacyclin and Peroxisome Proliferator- Activated Receptor Gamma in Lung Cancer,"NEMENOFF, RAPHAEL",UNIVERSITY OF COLORADO DENVER,CO,"$297,556"
Lung Cancer,2009,NCI,5P50CA058187-15,0021,The Biology of Pulmonary Premalignancy: Application to Risk Assessment and Chemop,"MILLER, YORK",UNIVERSITY OF COLORADO DENVER,CO,"$281,959"
Lung Cancer,2009,NCI,5P50CA058187-15,0022,Developmental Research Program,"BUNN, PAUL",UNIVERSITY OF COLORADO DENVER,CO,"$68,476"
Lung Cancer,2009,NCI,5P50CA058187-15,0023,Career Development Program,"MILLER, YORK",UNIVERSITY OF COLORADO DENVER,CO,"$68,476"
Lung Cancer,2009,NCI,5P50CA058187-15,9001,Tissue Bank and Biomarkers Core,"FRANKLIN, WILBUR",UNIVERSITY OF COLORADO DENVER,CO,"$338,068"
Lung Cancer,2009,NCI,5P50CA058187-15,9002,Clinical Trials Core,"KEITH, ROBERT",UNIVERSITY OF COLORADO DENVER,CO,"$283,326"
Lung Cancer,2009,NCI,5P50CA058187-15,9003,Biostatistics and Informatics Core,"BARON, ANNA",UNIVERSITY OF COLORADO DENVER,CO,"$268,012"
Lung Cancer,2009,NCI,5P50CA058187-15,9006,Administration Core,"BUNN, PAUL",UNIVERSITY OF COLORADO DENVER,CO,"$144,977"
Lung Cancer,2009,NCI,5P01CA087971-07,0005,Enhancing Direct Tumor Cell Cytotoxicity By Manipulating Growth Factor Signaling,"HAHN, STEPHEN",UNIVERSITY OF PENNSYLVANIA,PA,"$205,126"
Lung Cancer,2009,NCI,5P01CA087971-07,0008,PDT for NSCLC with pleural carcinomatosis,"FRIEDBERG, JOSEPH",UNIVERSITY OF PENNSYLVANIA,PA,"$160,895"
Lung Cancer,2009,NCI,5P01CA087971-07,9003,Biostatistics and Data Coordinating Core (BDCC),"PUTT, MARY",UNIVERSITY OF PENNSYLVANIA,PA,"$165,184"
Lung Cancer,2009,NCI,5P50CA090440-09,0006,Intersection of Estrogen Receptor Signaling and Epidermal Growth Factor Receptor,"SIEGFRIED, JILL",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$274,668"
Lung Cancer,2009,NCI,5P50CA090440-09,0007,"CYCLIN B1 IN IMMUNOTHERAPY, DIAGNOSIS, AND PROGNOSIS OF LUNG CANCER","FINN, OLIVERA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$318,569"
Lung Cancer,2009,NCI,5P50CA090440-09,0008,SERUM PROTEOMIC BIOMARKERS FOR LUNG CANCER DETECTION AND PROGNOSIS,"BIGBEE, WILLIAM",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$239,747"
Lung Cancer,2009,NCI,5P50CA090440-09,0009,NUCLEOTIDE EXCISION REPAIR/CELL CYCLE CONTROL HAPLOTYES AND LUNG CANCER RISK AND,"ROMKES, MARJORIE",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$318,835"
Lung Cancer,2009,NCI,5P50CA090440-09,0010,DEVELOPMENTAL RESEARCH PROGRAM,"BIGBEE, WILLIAM",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$108,785"
Lung Cancer,2009,NCI,5P50CA090440-09,0011,CAREER DEVELOPMENT PROGRAM,"GREENBERGER, JOEL",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$108,785"
Lung Cancer,2009,NCI,5P50CA090440-09,9001,TISSUE AND BLOOD BANK CORE,"DHIR, RAKIV",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$183,097"
Lung Cancer,2009,NCI,5P50CA090440-09,9003,BIOSTATISTICS/BIOINFORMATICS CORE,"LAND, STEPHANIE",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$87,392"
Lung Cancer,2009,NCI,5P50CA090440-09,9004,CLINICAL CORE,"WEISSFIELD, JOEL",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$516,409"
Lung Cancer,2009,NCI,N1CN75022A-63-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial","FOUAD, MONA",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$692,835"
Lung Cancer,2009,NCI,N1CN75022A-63-0-2,,National Lung Screening Trial,"FOUAD, MONA",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$924,380"
Lung Cancer,2009,NCI,N1CN25524A-78-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial","BUYS, SAUNDRA",UNIVERSITY OF UTAH,UT,"$734,554"
Lung Cancer,2009,NCI,N1CN25518A-92-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial","REDING, DOUGLAS",MARSHFIELD CLINIC RESEARCH FOUNDATION,WI,"$767,995"
Lung Cancer,2009,NCI,N1CN25518A-92-0-2,,National Lung Study Trial,"REDING, DOUGLAS",MARSHFIELD CLINIC RESEARCH FOUNDATION,WI,"$193,222"
Lung Cancer,2009,NCI,N1CN25516A-95-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial",NO PI IDENTIFIED,WASHINGTON UNIVERSITY,MO,"$611,560"
Lung Cancer,2009,NCI,N1CN25516A-95-0-2,,National Lung Screening Trial (NLST),NO PI IDENTIFIED,WASHINGTON UNIVERSITY,MO,"$950,956"
Lung Cancer,2009,NCI,N1CN25515A-87-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial","YOKOCHI, LANCE",PACIFIC HEALTH RESEARCH INSTITUTE,HI,"$1,078,239"
Lung Cancer,2009,NCI,N1CN25515A-87-0-2,,National Lung Study Trial,"YOKOCHI, LANCE",PACIFIC HEALTH RESEARCH INSTITUTE,HI,"$1,097,882"
Lung Cancer,2009,NCI,N1CN25514A-82-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial",NO PI IDENTIFIED,UNIVERSITY OF COLORADO DENVER,CO,"$1,327,312"
Lung Cancer,2009,NCI,N1CN25514A-82-0-2,,National Lung Screening Trial (NLST),NO PI IDENTIFIED,UNIVERSITY OF COLORADO DENVER,CO,"$845,536"
Lung Cancer,2009,NCI,N1CN25513A-93-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial","CHURCH, TIMOTHY",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$1,465,095"
Lung Cancer,2009,NCI,N1CN25513A-93-0-2,,National Lung Screening Trial (NLST),"CHURCH, TIMOTHY",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$898,802"
Lung Cancer,2009,NCI,N1CN25512A-107-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial","KVALE, PAUL",HENRY FORD HEALTH SYSTEM,MI,"$1,138,422"
Lung Cancer,2009,NCI,N1CN25512A-107-0-2,,National Lung Screening Trial (NLST),"KVALE, PAUL",HENRY FORD HEALTH SYSTEM,MI,"$638,440"
Lung Cancer,2009,NCI,N1CN25511A-88-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial","WEISSFELD, JOEL",,,"$632,887"
Lung Cancer,2009,NCI,5P01CA116676-04,0001,Modulation of the mTOR Pathway for Lung Cancer Treatment,"KHURI, FADLO",EMORY UNIVERSITY,GA,"$347,806"
Lung Cancer,2009,NCI,5P01CA116676-04,0002,Altered LKB1/AMPK Signaling and Chemosensitivity in NSCLC,"ZHOU, WEI",EMORY UNIVERSITY,GA,"$222,184"
Lung Cancer,2009,NCI,5P01CA116676-04,0003,Targeting Microtubules and HDAC6 in NSCLC,"GIANNAKAKOU, PARASKEVI",EMORY UNIVERSITY,GA,"$365,353"
Lung Cancer,2009,NCI,5P01CA116676-04,0004,Targeting 14-3-3-Mediated Survival,"FU, HAIAN",EMORY UNIVERSITY,GA,"$279,658"
Lung Cancer,2009,NCI,5P01CA116676-04,9001,Pathology and Molecular Analysis,"GAL, ANTHONY",EMORY UNIVERSITY,GA,"$178,836"
Lung Cancer,2009,NCI,5P01CA116676-04,9002,Biostatistics,"ROGATKO, ANDRE",EMORY UNIVERSITY,GA,"$134,761"
Lung Cancer,2009,NCI,N02CN63300-4-0-2,,Computer Support for Lung Cancer Screening in the PLCO Cancer Screening Trial,"LAKE, WILLIAM","INFORMATION MANAGEMENT SERVICES, INC.",MD,"$1,044,482"
Lung Cancer,2009,OD,2R56CA107510-06,,The role of p53 and 14-3-3 in genomic instability,"MARTINEZ, JESSE",UNIVERSITY OF ARIZONA,AZ,"$272,082"
Lung Cancer,2009,NCI,3R01CA129632-02S1,,microRNA regulation of drug sensitivity in non-small cell lung cancer,"PERTSEMLIDIS, ALEXANDER",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$20,317"
Lung Cancer,2009,NCI,3R01CA129632-03S2,,microRNA regulation of drug sensitivity in non-small cell lung cancer,"PERTSEMLIDIS, ALEXANDER",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$62,428"
Lung Cancer,2009,NCI,5P01CA059827-14,0009,INDIVIDUALIZED DOSE ESCALATION IN VOLUME-EFFECT ORGANS,"LAWRENCE, THEODORE",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$403,976"
Lung Cancer,2009,NCI,5P30CA082103-11,0011,TOBACCO CONTROL PROGRAM,"BENOWITZ, NEAL",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$71,725"
Lung Cancer,2009,NCI,4R00CA126147-03,,Developing approaches for modeling genomic and proteomic profiles in lung cancer,"MCMAHON, PAMELA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$244,393"
Lung Cancer,2009,NCI,4R00CA126026-03,,Role of EGFR mutations and new therapeutics in lung cancer,"KOBAYASHI, SUSUMU",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$249,000"
Lung Cancer,2009,NCI,5P50CA090578-07,0006,Genetic analysis of NSCLC survival,"CHRISTIANI, DAVID",DANA-FARBER CANCER INSTITUTE,MA,"$287,614"
Lung Cancer,2009,NCI,5P50CA090578-07,0007,Foxa2 and C/EBP transcription factors in the pathogenesis and treatment of lung c,"TENEN, DANIEL",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$329,052"
Lung Cancer,2009,NCI,5P50CA090578-07,0008,Targeting erlotinib-resistant lung cancer with rational combination treatments,"SETTLEMAN, JEFFREY",MASSACHUSETTS GENERAL HOSPITAL,MA,"$340,249"
Lung Cancer,2009,NCI,5P50CA090578-07,0009,Translational studies of Hsp90 inhibitors in NSCLC,"SHAPIRO, GEOFFREY",DANA-FARBER CANCER INSTITUTE,MA,"$195,254"
Lung Cancer,2009,NCI,5P50CA090578-07,0010,Mechanisms of acquired resistance to EGFR-targeted agents,"JANNE, PASI",HARVARD UNIVERSITY (SCH OF PUBLIC HLTH),MA,"$270,317"
Lung Cancer,2009,NCI,5P50CA090578-07,0011,Developmental Research Program,"JOHNSON, BRUCE",DANA-FARBER CANCER INSTITUTE,MA,"$54,788"
Lung Cancer,2009,NCI,5P50CA090578-07,0012,Career Development Program,"CHRISTIANI, DAVID",DANA-FARBER CANCER INSTITUTE,MA,"$54,788"
Lung Cancer,2009,NCI,5P50CA090578-07,9001,CA: Tissue and Pathology,"LODA, MASSIMO",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$263,032"
Lung Cancer,2009,NCI,5P50CA090578-07,9002,CC: Biostatistics,"YEAP, BEOW",MASSACHUSETTS GENERAL HOSPITAL,MA,"$141,780"
Lung Cancer,2009,NCI,5P50CA090578-07,9004,"CB: Administration, Evaluation, and Planning","JOHNSON, BRUCE",DANA-FARBER CANCER INSTITUTE,MA,"$239,243"
Lung Cancer,2009,NCI,5P50CA090578-07,9005,CD: Genomics and Bioinformatics,"MEYERSON, MATTHEW",DANA-FARBER CANCER INSTITUTE,MA,"$123,883"
Lung Cancer,2009,NCMHD,5P20MD003352-02,0001,The Effect of Isothiocyanate Consumption on NNAL Metabolism in Smokers,"HULL, ANNA",LINCOLN UNIVERSITY,PA,"$402,151"
Lung Cancer,2009,NCI,N1CN25476A-81-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial","O'BRIEN, BARBARA","WESTAT, INC.",MD,"$2,102,638"
Lung Cancer,2009,NCI,N1CN25476A-81-0-2,,National Lung Screening Trial,"O'BRIEN, BARBARA","WESTAT, INC.",MD,"$1,620,738"
Lung Cancer,2009,NCI,5P01CA129243-03,0001,Brain-Specific Metastasis Genes,"MASSAGUE, JOAN",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$356,273"
Lung Cancer,2009,NCI,5P01CA129243-03,0002,KRAS- and BRAF- Driven Lung Adenocarcinoma,"ROSEN, NEAL",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$352,058"
Lung Cancer,2009,NCI,5P01CA129243-03,0003,EGFR Kinase Inhibitor-Persistent EGFR-Mutant Lung Adenocarcinoma,"PAO, WILLIAM",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$220,515"
Lung Cancer,2009,NCI,5P01CA129243-03,0004,Targeting EGFR and KRAS Mutations,"VARMUS, HAROLD",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$390,356"
Lung Cancer,2009,NCI,5P01CA129243-03,9001,Molecular Profiling and Pathology,"LADANYI, MARC",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$421,488"
Lung Cancer,2009,NCI,5P01CA129243-03,9002,Information Engineering,"LASH, ALEX",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$175,070"
Lung Cancer,2009,NCI,5P01CA066726-13,0004,Clinical Trials in Mesothelioma,"STERMAN, DANIEL",UNIVERSITY OF PENNSYLVANIA,PA,"$472,015"
Lung Cancer,2009,NCI,5P01CA066726-13,0006,Immunogene Ther. of Mesothelin Express. Tumors Using Lentiviral Engineered TCells,"JUNE, CARL",UNIVERSITY OF PENNSYLVANIA,PA,"$173,831"
Lung Cancer,2009,NCI,5P30CA086862-10,6935,Tumor Imaging,"GRAHAM, MICHAEL",UNIVERSITY OF IOWA,IA,"$22,489"
Lung Cancer,2009,NCI,3U01CA085070-10S1,,Colorado Biomarkers Development Laboratory,"FRANKLIN, WILBUR",UNIVERSITY OF COLORADO DENVER,CO,"$341,209"
Lung Cancer,2009,NCI,3U01CA084986-10S2,,Integrated Development of Novel Molecular Markers,"SIDRANSKY, DAVID",JOHNS HOPKINS UNIVERSITY,MD,"$525,456"
Lung Cancer,2009,NCI,3U01CA084982-10S1,,Proteomics Biomarkers Development Laboratory,"HANASH, SAMIR",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$443,657"
Lung Cancer,2009,NHLBI,5P01HL091842-02,9003,Imaging Core,"MCLENNAN, GEOFFREY",UNIVERSITY OF IOWA,IA,"$157,128"
Lung Cancer,2009,NCI,5P01CA021239-30,0007,Proton Dose Escalation and Proton vs. Photon Randomized Trials,"KOMAKI, RITSUKO",MASSACHUSETTS GENERAL HOSPITAL,MA,"$396,935"
Lung Cancer,2009,NCI,5P01CA042063-24,0012,Investigaton of Small Regulatory RNAs in Tumor Development,"JACKS, TYLER",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$400,404"
Lung Cancer,2009,NIGMS,3R01GM076343-04S2,,Structural Basis of Cytochrome P450 2A13 Activity,"SCOTT, EMILY",UNIVERSITY OF KANSAS LAWRENCE,KS,"$16,531"
Lung Cancer,2009,NCI,N1CN25522A-95-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial","ISAACS, CLAUDINE",GEORGETOWN UNIVERSITY,DC,"$649,306"
Lung Cancer,2009,NCI,N1CN25522A-95-0-2,,National Lung Screening Trial (NLST),"ISAACS, CLAUDINE",GEORGETOWN UNIVERSITY,DC,"$420,380"
Lung Cancer,2009,NCI,7R01CA112385-06,,Pharmacodynamic Assessment of RTK Inhibitors in Cancer,"HALLAHAN, DENNIS",WASHINGTON UNIVERSITY,MO,"$190,567"
Lung Cancer,2009,NCI,3U01CA084971-10S1,,Novel Reagents and New Biomarkers for Lung Cancer,"GAZDAR, ADI",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$307,500"
Lung Cancer,2009,NCI,5U54CA119349-05,0002,TREATMENT OF CANCER WITH siRNA DELVIERED BY NANOPARTICLES,"SHARP, PHILLIP",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$662,760"
Lung Cancer,2009,NCI,5U54CA119349-05,9003,PILOT STUDIES,"LANGER, ROBERT",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$226,574"
Lung Cancer,2009,NCI,5U54CA119349-05,9005,MOUSE MODEL CORE,"HOUSMAN, DAVID",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$196,460"
Lung Cancer,2009,NCI,5P50CA070907-12,0009,P-1: Molecular Signatures for Individualizing Lung Cancer Therapy,"MINNA, JOHN",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$260,955"
Lung Cancer,2009,NCI,5P50CA070907-12,0010,P-2: Risk Prediction of platinum-based chemotherapy and Radiotherapy Outcome,"WU, XIFENG",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$354,719"
Lung Cancer,2009,NCI,5P50CA070907-12,0011,P-3: Targeting Tumor Microenvironment in NSCLC,"KURIE, JONATHAN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$251,519"
Lung Cancer,2009,NCI,5P50CA070907-12,0012,P-4: Therapeutic Targeting of Telomerase and Lung Cancer,"SHAY, JERRY",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$185,380"
Lung Cancer,2009,NCI,5P50CA070907-12,0013,P-5: Translation of the 3p21.3 Gene FUS1 into Pathway-Targeted Molecular Therapy,"ROTH, JACK",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$279,516"
Lung Cancer,2009,NCI,5P50CA070907-12,0014,Developmental Research Program,"ROTH, JACK",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$70,607"
Lung Cancer,2009,NCI,5P50CA070907-12,9004,CB: Tissue Resources and Molecular Pathology,"WISTUBA, IGNACIO",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$258,436"
Lung Cancer,2009,NCI,5P50CA070907-12,9005,CA: Administration Core,"MINNA, JOHN",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$220,871"
Lung Cancer,2009,NCI,5P50CA070907-12,9006,CC: Biostatistics Core,"COOMBES, KEVIN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$237,711"
Lung Cancer,2009,NCI,5P50CA070907-12,9007,CD: Bioinformatics Core,"GARNER, HAROLD",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$109,679"
Lung Cancer,2009,NCI,5P50CA070907-12,9008,Career Development Program,"ROTH, JACK",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$70,607"
Lung Cancer,2009,NCI,N1CN25404A-41-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial - Lab",NO PI IDENTIFIED,UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$932,550"
Lung Cancer,2009,NCI,5P50CA095817-07,0005,ICCS in Lung Cancer: Evaluating Survival Benefits,"CLEARY, JAMES",UNIVERSITY OF WISCONSIN MADISON,WI,"$287,963"
Lung Cancer,2009,NCI,5P50CA119997-02,0001,E2F's impact on Therapeutic Efficacy,"CRESS, DOUG",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$301,620"
Lung Cancer,2009,NCI,5P50CA119997-02,0002,Antitumor Mechanisms of SRC Inhibitors in Lung Cancer,"HAURA, ERIC",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$352,790"
Lung Cancer,2009,NCI,5P50CA119997-02,0003,Lung Cancer Chemoprevention with Enzastaurin,"BEPLER, GEROLD",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$357,904"
Lung Cancer,2009,NCI,5P50CA119997-02,0004,P-53-Based Vaccine for Small Cell Lung Cancer,"GABRILOVICH, DMITRY",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$350,392"
Lung Cancer,2009,NCI,5P50CA119997-02,0005,Development Research Program,"BEPLER, GEROLD",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$94,507"
Lung Cancer,2009,NCI,5P50CA119997-02,0006,Career Development Program,"HAURA, ERIC",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$94,505"
Lung Cancer,2009,NCI,5P50CA119997-02,9001,"CA: Tissue Procurement, Pathology, and Biomedical Informatics","ALTOIK, SONER",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$208,731"
Lung Cancer,2009,NCI,5P50CA119997-02,9002,CB: Clinical Trials and Biostatistics Core,"SIMON, GEORGE",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$346,857"
Lung Cancer,2009,NCI,5P50CA119997-02,9003,CC: Administration and Patient Advocacy,"BEPLER, GEROLD",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$209,762"
Lung Cancer,2009,NCI,3R01CA131348-02S1,,Prognosis and Effectiveness of Advanced Lung Cancer Treatment in the Elderly,"WISNIVESKY, JUAN",MOUNT SINAI SCHOOL OF MEDICINE OF NYU,NY,"$92,016"
Lung Cancer,2009,NCI,5P01CA114047-04,0001,GENE ENVIRONMENT INTERACTIONS IN MESOTHELIOMA,"CARBONE, MICHELE",UNIVERSITY OF HAWAII AT MANOA,HI,"$432,670"
Lung Cancer,2009,NCI,5P01CA114047-04,0002,ERK PATHWAYS IN PATHOGENESIS OF MESOTHELIOMA,"MOSSMAN, BROOKE",UNIVERSITY OF VERMONT & ST AGRIC COLLEGE,VT,"$336,464"
Lung Cancer,2009,NCI,5P01CA114047-04,0003,AKT AND TUMOR SUPPRESSOR PATHWAYS IN MESOTHELIOMA,"TESTA, JOSEPH",FOX CHASE CANCER CENTER,PA,"$379,860"
Lung Cancer,2009,NCI,5P01CA114047-04,9001,CLINICAL CORE,"PASS, HARVEY",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$114,283"
Lung Cancer,2009,NCI,5P01CA114047-04,9002,"PATHOLOGY, VIROLOGY, AND ANIMAL CORE","CARBONE, MICHELE",UNIVERSITY OF HAWAII AT MANOA,HI,"$280,062"
Lung Cancer,2009,NCI,3R01CA119029-04S1,,Development of DNA Methylation Markers for Early Detection of Lung Cancer,"LAIRD-OFFRINGA, ITE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$50,978"
Lung Cancer,2009,NCI,5U54CA119338-05,0003,Multiplexed Nanoparticle Probes for Therapeutic Translational Oncology,"SIMONS, JONATHAN",EMORY UNIVERSITY,GA,"$379,473"
Lung Cancer,2009,NHLBI,268200900007C-1-0-1,,BIOMEDICAL (BASIC),"HANASH, SAMIR",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$859,015"
Lung Cancer,2009,NCI,2P30CA016042-34,5636,Thoracic Oncology,"DUBINETT, STEVEN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$44,106"
Lung Cancer,2009,NCI,2P30CA077598-11,5746,Carcinogenesis & Chemoprevention,"HECHT, STEPHEN",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$29,155"
Lung Cancer,2009,NCRR,5M01RR010732-15,6590,SOMATIC ANXIETY & DISTRESS: A STRESS-DIATHESIS MODEL IN CANCER SURVIVORS,"ARONSON, KEITH",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$3,235"
Lung Cancer,2009,NCRR,5M01RR000400-41,7071,DETERMINING AND COMPARING THE PHARMACOKINETICS OF [D10]PHE IN SMOKERS AFTER ORAL,"HECHT, STEPHEN",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$8,782"
Lung Cancer,2009,NCRR,5M01RR000425-40,7555,TRANSCRIPTIONAL REGULATION OF A FUMIGATUS VIRULENCE,"FILLER, SCOTT",LA BIOMED RES INST/ HARBOR UCLA MED CTR,CA,"$6,422"
Lung Cancer,2009,NCRR,5M01RR000071-46,7851,EFFECTS OF A DIETARY SUPPLEMENT ON NON-SMALL CELL LUNG CANCER PATIENTS,"SACKS, HENRY",MOUNT SINAI SCHOOL OF MEDICINE OF NYU,NY,"$1,224"
Lung Cancer,2009,NCRR,5P41RR000862-36,8263,STUDYING EGFR INTERACTING PARTNERS,"VARMUS, HAROLD",ROCKEFELLER UNIVERSITY,NY,"$1,190"
Lung Cancer,2009,NCRR,5P41RR001192-30,5005,HIGH RESOLUTION OPTICAL DIAGNOSTICS FOR ORAL AND LUNG CANCER,"CHEN, ZHONGPING",UNIVERSITY OF CALIFORNIA IRVINE,CA,"$3,016"
Lung Cancer,2009,NCRR,5P41RR001192-30,5069,DECTECTION OF EARLY CANCER USING FUNCTIONAL OPTICAL COHERENCE TOMOGRAPHY,"CHEN, ZHONGPING",UNIVERSITY OF CALIFORNIA IRVINE,CA,"$3,016"
Lung Cancer,2009,NCRR,5P41RR005959-20,7149,HYPERPOLARIZED 3HE MR-LUNG CANCER LESIONS TAGGED BY TARGETED SPIONS,"BRANCA, ROSA",DUKE UNIVERSITY,NC,"$10,920"
Lung Cancer,2009,NCRR,5P41RR005959-20,7151,IMAGING LUNG CANCER IN MICE TO IMPROVE RADIATION THERAPY,"KIRSCH, DAVID",DUKE UNIVERSITY,NC,"$10,920"
Lung Cancer,2009,NCRR,5P41RR005959-20,7156,IMAGING EGFR WITH MICRO-PET AND I-124,"PATZ, EDWARD",DUKE UNIVERSITY,NC,"$5,460"
Lung Cancer,2009,NCRR,5P41RR005959-20,7181,CELLS OF ORIGIN OF LUNG CANCER,"ONAITIS, MARK",DUKE UNIVERSITY,NC,"$5,460"
Lung Cancer,2009,NCRR,2P51RR000163-50,8619,ACETYLCHOLINE AND NICOTINIC RECEPTORS IN LUNG CANCER,"SPINDEL, ELIOT",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$78,561"
Lung Cancer,2009,NIA,2P51RR000163-50,8619,ACETYLCHOLINE AND NICOTINIC RECEPTORS IN LUNG CANCER,"SPINDEL, ELIOT",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$1,782"
Lung Cancer,2009,NCRR,2P51RR000163-50,8708,CHOLINE TRANSPORTERS SPECIFICALLY TARGET NON-NEURONAL ACETYLCHOLINE SYNTHESIS,"SONG, PILL-SOON",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$59,053"
Lung Cancer,2009,NIA,2P51RR000163-50,8708,CHOLINE TRANSPORTERS SPECIFICALLY TARGET NON-NEURONAL ACETYLCHOLINE SYNTHESIS,"SONG, PILL-SOON",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$1,340"
Lung Cancer,2009,NCRR,5P20RR015563-10,5582,NANOPARTICLE-BASED DUAL GENE THERAPY FOR LUNG ADENOCARCINOMA,"TAMURA, MASAAKI",UNIVERSITY OF KANSAS LAWRENCE,KS,"$45,139"
Lung Cancer,2009,NCRR,5P20RR017670-08,5734,RESPONSE IN LUNG EXTRACELLULAR MATRIX TO ASBESTOS,"PUTNAM, ELIZABETH",UNIVERSITY OF MONTANA,MT,"$107,781"
Lung Cancer,2009,NCRR,5P20RR016462-08,6071,CREB-TARGET GENES IN MALIGNANT MESOTHELIOMA,"SHUKLA, ARTI",UNIVERSITY OF VERMONT & ST AGRIC COLLEGE,VT,"$6,811"
Lung Cancer,2009,NCRR,2P20RR016472-09,6349,3D IMAGE ANAL ALGORITHMS FOR AUTOMATIC COMP OF GROUND-GLASS OPACITY LUNG TUMOR,"KAMBHAMETTU, CHANDRA",UNIVERSITY OF DELAWARE,DE,"$54,591"
Lung Cancer,2009,NCRR,5P20RR018787-07,6539,COBRE P1: MOLECULAR MECHANISMS OF AURORA KINASE A DYSFUNCTION IN LUNG CANCER,"GERBER, SCOTT",DARTMOUTH COLLEGE,NH,"$267,484"
Lung Cancer,2009,NCRR,2P20RR017695-06A2,6674,COBRE: RIH:CORE A: ADMINISTRATION & CAREER DVMT,"HIXSON, DOUGLAS",RHODE ISLAND HOSPITAL,RI,"$469,035"
Lung Cancer,2009,NCI,261200900046C-0-0-1,,SBIR PROPOSAL FOR PHS 2009-1 TOPIC 266 FOR A TARGETED NANOCOMPLIX FOR EARLY DETE,"LI, CHOU-CHI","SYNERGENE THERAPEUTICS, INC.",DC,"$199,978"
Lung Cancer,2009,NCI,1ZIABC005399-26,,Mechanistic Targeting of Lung Cancer,"ANDERSON, LUCY",NIH,,"$689,893"
Lung Cancer,2009,NCI,1ZIABC005480-24,,Molecular Epidemiology of Human Lung Cancer,"HARRIS, CURTIS",NIH,,"$786,156"
Lung Cancer,2009,NCI,1ZIABC005488-24,,Mechanisms of Inorganic Carcinogenesis,"WAALKES, MICHAEL",NIH,,"$1,628,694"
Lung Cancer,2009,NCI,1ZIABC008753-27,,Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies,"PASTAN, IRA",NIH,,"$2,131,560"
Lung Cancer,2009,NCI,1ZIABC010033-14,,Inflammation and Cancer,"HARRIS, CURTIS",NIH,,"$733,746"
Lung Cancer,2009,NCI,1ZIABC010448-07,,Genetic Alterations in Lung Cancer,"WIEST, JONATHAN",NIH,,"$244,256"
Lung Cancer,2009,NCI,1ZIABC010748-04,,Clinical Investigation of Signal Transduction Inhibitors,"DENNIS, PHILLIP",NIH,,"$695,684"
Lung Cancer,2009,NCI,1ZIABC010816-03,,Immunotherapy for Malignant Mesothelioma,"HASSAN, RAFFIT",NIH,,"$725,065"
Lung Cancer,2009,NCI,1ZIABC010853-03,,Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide,"KLINMAN, DENNIS",NIH,,"$403,079"
Lung Cancer,2009,NCI,1ZIABC010854-03,,Lung Cancer Program,"GIACCONE, GIUSEPPE",NIH,,"$1,574,861"
Lung Cancer,2009,NCI,1ZIABC010874-02,,Biomarkers of Human Lung Cancer,"HARRIS, CURTIS",NIH,,"$733,746"
Lung Cancer,2009,NCI,1ZIABC010889-02,,Role of Selenium-containing Proteins in Cancer and Development,"HATFIELD, DOLPH",NIH,,"$304,554"
Lung Cancer,2009,NCI,1ZIABC010891-02,,Antibody Therapy of Cancer,"HO, MITCHELL",NIH,,"$661,164"
Lung Cancer,2009,NCI,1ZIABC011046-02,,Mechanisms of apoptosis regulation which impede cancer cell death in lung cancer,"KWONG, KING",NIH,,"$312,939"
Lung Cancer,2009,NCI,1ZIABC011049-02,,Development and evaluation of apoptosis targeted therapies in lung cancer,"KWONG, KING",NIH,,"$322,422"
Lung Cancer,2009,NCI,1ZIABC011108-02,,MAP Kinase signal transduction disruption in cancer,"WIEST, JONATHAN",NIH,,"$244,256"
Lung Cancer,2009,NCI,1ZIABC011115-02,,Epigenetic Mechanisms of Gene Expression in Lung Cancer Cells,"SCHRUMP, DAVID",NIH,,"$689,820"
Lung Cancer,2009,NCI,1ZIABC011122-02,,Epigenetic Alterations Induced by Tobacco Smoke,"SCHRUMP, DAVID",NIH,,"$965,749"
Lung Cancer,2009,NCI,1ZIABC011160-01,,Mechanisms in development & regulation of metastasis in lung cancer,"KWONG, KING",NIH,,"$312,939"
Lung Cancer,2009,NCI,1ZIABC011167-01,,A novel preclinical model of spontaneous metastasis,"MERLINO, GLENN",NIH,,"$461,518"
Lung Cancer,2009,NCI,1ZIABC011204-01,,Preclinical development of AlaTIMP-2 as an cancer therapeutic,"STETLER-STEVENSON, WILLIAM",NIH,,"$1,012,438"
Lung Cancer,2009,NCI,1ZIABC011217-01,,Preclinical Characterization of Drugs in Mouse Model of Lung Cancer,"TESSAROLLO, LINO",NIH,,"$1,090,467"
Lung Cancer,2009,NCI,1ZIACP005804-15,,Pharmacogenetic Studies,"CAPORASO, NEIL",NIH,,"$627,804"
Lung Cancer,2009,NCI,1ZIACP010120-14,,Studies of Occupational Cancer,"LAN, QING",NIH,,"$2,460,178"
Lung Cancer,2009,NCI,1ZIACP010125-14,,Cancer Risk and Environmental Exposures,"WARD, MARY",NIH,,"$2,444,433"
Lung Cancer,2009,NCI,1ZIACP010136-14,,Cancer Risk in Human Populations,"SILVERMAN, DEBRA",NIH,,"$1,123,133"
Lung Cancer,2009,NCI,1ZIACP010169-08,,"Nutrition, Metabolism, and Cancer","ZIEGLER, REGINA",NIH,,"$366,544"
Lung Cancer,2009,NCI,1ZIACP010200-03,,GEI - Genome-Wide Association Studies,"FRAUMENI, JOSEPH",NIH,,"$191,638"
Lung Cancer,2009,NIEHS,1ZIAES101574-07,,Genetic and environmental factors in cancer,"LONDON, STEPHANIE",NIH,,"$67,159"
Lung Cancer,2009,NHGRI,1ZIAHG200331-05,,Genetic Epidemiology of Cancer,"BAILEY-WILSON, JOAN",NIH,,"$776,735"
Lung Cancer,2009,NCI,1ZIASC000167-18,,Molecular Pathology of Pulmonary Carcinogenesis,"LINNOILA, ILONA",NIH,,"$1,126,875"
Lung Cancer,2009,NCI,1ZIASC007256-21,,Mechanisms of Oncogene Action in Tumorigenesis,"KAYE, FREDERIC",NIH,,"$804,273"
Lung Cancer,2009,NCI,1ZIASC010093-13,,Targeting the Epigenome for Lung Cancer Therapy,"SCHRUMP, DAVID",NIH,,"$1,103,712"
Lung Cancer,2009,NCI,1ZIASC010292-11,,Signal Transduction Pathways that Promote Survival of Lung Cancer Cells,"DENNIS, PHILLIP",NIH,,"$1,391,366"
Lung Cancer,2009,NIA,1ZICAG000617-02,,Application of analytical cytology to current issues in the biomedical sciences,"WERSTO, ROBERT",NIH,,"$23,979"
Lung Cancer,2009,NCI,1ZICBC010630-06,,Cancer Vaccines and Modulation of Checkpoint Controls in Immunization,"JANIK, JOHN",NIH,,"$835,947"
Lung Cancer,2009,NCI,1ZICBC011040-02,,Molecular Profiling of Clinical Specimens,"EDELMAN, DANIEL",NIH,,"$1,686,909"
Lung Cancer,2009,NCRR,2P41RR013461-11,8429,OXIDIZED  DNA BASES AS BIOMARKERS OF TUMOR PROGRESSION,"HENDERSON, PAUL",UNIVERSITY OF CALIF-LAWRNC LVRMR NAT LAB,CA,"$68,313"
